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I . IlgflQ&UCIIQJ^ 
An enzyme i s a b ioca t a ly s t tha t ca ta lyses a thermo-
dynamicalQy feas ib le react ion so t h a t the ra te of the reac t ion 
i s comptaible with the biochemical process e s s e n t i a l for the 
maintenance of a c e l l . 
The s t r i k ing c h a r a c t e r i s t i c s of a l l enzymes au:*e t h e i r 
c a t a l y t i c power and s p e c i f i c i t y . The o r ig ina l model of a 
c a t a l y t i c s i t e , prq .^-^ ."-"'- •..• r,<flii Fischer i£ :r-?l'?;:^i? to lock 
and key arrangement or r i g i d template model. The 'induced f i t ' 
model of Koshland i s the more accepted hypothesis . An essen-
t i a l feature of the l a t t e r model i s the f l e x i b i l i t y of the 
c a t a l y t i c s i t e unl ike the Fischer model where the c a t a l y t i c 
s i t e i s supposed to be preshaped to f i t the s u b s t r a t e . 
I n the induced f i t model, the subs t ra te induces a 
conformational change i n the enzyme. This a l igns amino acid 
res idues or other groups on the enzyme in the correct specia l 
o r i en t a t i on for the substra te binding and c a t a l y s i s or both . 
Simultaneously other amino acid residues may become buried i n 
the i n t e r i o r of t^e molecule. 
A. General P roper t i e s of Enzvmesi 
Enzymes unl ike inorganic ca ta lys t are highly speci f ic 
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and e f f i c i e n t . The enzyme molecule i s able to speci f ica l ly 
s e l ec t i t s subs t ra te through i n t e r a c t i o n a t the active cent re . 
Only a f rac t ion of t o t a l amino acid res idues i n an enzyme 
molecule cons t i tu t e s active centre or active s i t e . The geo-
metry of active s i t e i s maintained by the r e s t of the amino 
acid sequence of the enzyme. The act ive centre usually takes 
the shape of a c l e f t where the d i e l e c t r i c constant of the 
medium i s low, A low d i e l e c t r i c oonstant favours non-covalent 
i n t e r a c t i o n of the enzyme with the s u b s t r a t e . 
An enzyme usually exh ib i t s group spec i f i c i ty i . e . 
ac t s only on p a r t i c u l a r chemical groupings. Thus a se r ies 
of aldohexoses may be phosphorylated by a kinase and kTB» 
I f the enzyme a t tacks only one subs t ra te i t i s cal led 
absolute group s p e c i f i c i t y . I t may have a r e l a t i v e group 
s p e c i f i c i t y , i f i t a t tacks a homologous s e r i e s of aldohexoses. 
Another important aspect of enzyme spec i f i c i ty i s the enzyme's 
s t e r eospec i f i c i t y towards the s u b s t r a t e . With the exception 
of epimerases, which in te rconver t op t i ca l isomers, enzymes 
general ly show absolute op t i ca l spec i f i c i ty for a t l e a s t a 
por t ion of a subs t ra te molecule. Many subs t r a t e s apparently 
form three bonds with enzymes. This ' t h r e e po in t attachment' 
gives asymmetry on an otherwise symmetric molecule. 
Enzymes do not a l t e r reac t ion e q u i l i b r i a as i t 
acce lera tes the forward reac t ion by the same fac to r . In other 
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words, they accelera te the attainment of e q u i l i b r i a but do not 
s h i f t t h e i r p o s i t i o n s . 
Enzymes decrease the ac t iva t ion energies (AG ) of 
r eac t ion , catalysed by them and thus accelera te the reac-
t i o n s by increas ing the f rac t ion of molecules having free 
energy equal t o or g rea te r than AG.. (AG, = G-transi t ion s t a t e -
G» subs t ra te )* 
, The jpate of reac t ion catalysed by an enzyme i s marhpdly 
influenced by concentration of enzyme and s u b s t r a t e , pH of 
the media and temperature a t which the reac t ion i s car r ied 
out . Other var iab les which affect enzyme catalysed reac t ion 
include ac t iva to r s and i n h i b i t o r s . 
Most of the enzyme catalysed reac t ions follow Michaelis-
Menten k i n e t i c s . Michaelis-Menten equation i s based on steady 
s t a t e hypothesis . Mathematically the Michaelis-Menten equa-
t i on can be expressed ass 
^ = Kjj, -f ( S ) "^"^  
Where V i s observed veloci ty a t a subs t ra te concentra-
t i on S: K i s Michaelis Menten constant and V ^ i s maximum 
IB max 
a t t a inab le veloci ty obtained at sa tu ra t ion concentrat ion of 
the subs t r a t e . The steady s t a t e hypothesis , simply s t a t e d . 
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Implies t h a t the concentrat loa of £S complex remains the same 
regardless of time. The cooplex does not accumulate during 
the react ion because the r a t e of I t s formation I s equal t o 
the r a t e of d i s soc i a t i on . 
When V I s p lo t ted against S, a rectangular hjrperbolic 
curve I s obtained. The value of V^^ can be computed frcm 
ex t rapo la t ion of the sa tu ra t ion curve t o zero subs t ra te 
concentrat ion. According t o equation (1) IL^ I s equal to 
subst ra te concentration where the observed velocltj^ i s half 
of the maximum a t ta inab le ve loc i ty . The constant , K^ ,^ 
measures the a f f ln t ly of the enzyme for the s u b s t r a t e . The 
constants K^ and V together define eff iciency of the 
enzyme and can be determined graphical ly by p lo t t i ng 1/V vs . 
1/(S) as suggested by Llneweaver and Burk (1) 
Among the ex te rna l var iab les which are known to 
influence enzyme ac t i v i t y are pH and temperature. pH in f l u -
ences the s t a t e of ion i sa t lon of ionlzable groups i n enzyme/ 
subs t ra te molecule. At extreme pH values , the molecules may 
undergo gross conformational change which w i l l d r a s t i c a l l y 
d i s rup t the nat ive enzyme conformation and thereby abolish 
i t s enzymatic a c t i v i t y . The pH ac t iv i ty p ro f i l e i s often 
b e l l shaped with *acid* and * alkaline* arms and a po in t / 
region where enzyme shows maximum a c t i v i t y . This pH i s called 
pH optimum. 
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Temperature influences enzyme catalysed reac t ion by 
( i ) increasing nuiBber ot effective collisions between subst ra te 
molecules and ( i i ) by denaturing the enzyme. The f i r s t factor 
enhances the ra t e of reac t ion whereas the second wil3 have 
the opposite e f f ec t . At low temperature, velocity increases 
with increase in tenpera ture because of tiie preponderance of 
f i r s t factor t i l l a temperature i s reached beyond which 
fur ther heat w i l l decrease the enzyme ac t i v i t y due t o the 
f-act tha t the- se^ o^-rid fact*-^ offsets^ the f i r s t Dne^  The 
temperature a t which maximum enzyme a c t i v i t y i s obtained 
i s cal led optimum tenpera ture . 
B. Begulation of Enzvme Ac?t^j.vity; The regula t ion of ac t iv i ty 
of enzyme in body t i s sue i s v i a t a i i y importai-it for overall 
b i o l c ^ i c a l control and espec ia l ly the r a t e of metabolism. 
The ac t i v i t y can be regulated e i t h e r by control l ing the 
c e l l u l a r l eve l of enzymes or by influencing the c a t a l y t i c 
efficiency of enzyme. The l a t t e r represents a f iner cont ro l . 
The l eve l of enzyme i n body t i s s u e i s determined by 
the ra t e at which the enzyme i s synthesized as well as by 
the ra te of degradat ion. The b iosynthes i s of enzyme i s prima-
r i l y control led at the l e v e l of DNA. The gene expression 
can be induced, repressed or derepressed. Degradation of 
enzyme has a t t r ac ted considerable a t t en t ion in recent years . 
S t ruc tu ra l fea tures of the enzyme which are prone to proteo-
l y t i c a t tack have been studied ( 1 a ) . Although a great deal 
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has been learned regarding the s t a b i l i t y of enzyme in vivo, 
much remains to be done for formulating a general mechanism 
of p ro te in degradation. Regardless of the mechanism of 
p ro te in degradation, the process seems to be regulated by 
the l eve l of pro te inases and proteinase i n h i b i t o r s . 
The c a t a l y t i c ac t i v i t y of enzyme can a lso be regula-
ted e i t h e r by covalent modification or by the help of effec-
t o r s or modulators. The covalent modification may include 
conve2*Sion or zymogen zc easyjae and cheadotu. wwuifiv-j^tion 
of spec i f ic amino acid res idues on enzyme molecules. I n 
a l l o s t e r i c regu la t ion , low molecular weight substances inc lu -
ding subs t ra tes can influence the enzyme a c t i v i t y by non-
covalent i n t e r ac t i on with the enzyme. The binding of e f fec -
t o r s or modulators may sh i f t the equil ibrium T -^ —»• R, where 
T and R represents respec t ive ly , tense and relaxed conforma-
t i o n of enzyme. In the relaxed conformation, the enzyme 
possesses marked a f f in i ty for subs t ra te whereas i n tense 
conformation, i t has neg l ig ib le a f f in i ty for the subs t r a t e . 
The enzymes are c l a s s i f i ed r a t i o n a l l y oo the bas i s of 
react ion types and reac t ion mechanisms. In t h i s I .U.B. system 
of c l a s s i f i c a t i o n , enzymes are divided i n t o s ix major c lasses , 
each with M—13 subclasses . 
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TABI£ 1: CLASSIFICATION OF ENZYMES. 
Main c lass and subclasses Example 
1< 0?ti(j^Qrg(^tt9tag9s: 
1 . 1 . Acting on > CHOH gr . of donors 
1 .1 .1 . with NAD or NADP as acceptor Alcohol dehydrogenase, IDE 
glucose oxidase. 
1 .1 .3 . with O2 as acceptor 
1.2. Acting on CHO or CO gr . of donors 
1 .2 .1 . with NAD or NADP as 
acceptor. 
, 1 * 2 . 3 . with Og as acceptor 
Gly ceroldehyde-3~phosphate 
dehydrogenase 
Xanthine oxlds??"*-
2. xrangferagggt 
2 . 1 . Transferring 0^ groups 
2 . 1 . 1 . Methyl t r ans fe rases 
2 . 1 , 3 , Carboxyl and carbamoyl 
t ransferase 
2 , 3 , Acyl t ransfe rases 
2 . 6 , Transfering N-containing groups 
2 . 6 . 1 , Aminotransferases 
Guanidino ace ta te methyl 
t r a n s f e r a s e . 
Ornithine carbamoyl t r a n s -
fe rase . 
Choline ace ty l t r ans fe rase . 
Transaminases. 
3«1- Cleaving e s t e r l inkages 
3«1 .1 . Carboxylic e s t e r 
hydrolases 
3»1.3« Phosphoric monoester 
hydrolases 
3 .2 . Cleaving glycosides 
3*2 .1 . Glyco;gJ.dase 
3«2.3« N-glycosidase 
Es te rases^ l ipases 
Phosphatases 
Amylase, B glucosidase 
Nucleosidases 
TABLE l i COHTIHUED.. 
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Main c lass and subclasses Examples 
3 . ^ . Cleaving peptide l inkages 
3 .V.1 . ^ a m i n o peptide amino 
acid hydrolases 
S.ifA. Peptidopeptlde hydrolases 
^ . 1 . C-C lyases 
^ . 1 . 1 . Carboxy^jases 
U-.1.2. Aldehyde lyases 
If,2. C-C lyases 
U-.2,1, Hydrolyases 
5 . 1 . Racemases and eplmerases 
5*1 O* Acting on carbohydrate 
5 .2 . Gis- t rans isomerases 
5.3« Intramolecular oxidoreductase 
5 .^ . Intramolecular t r ans fe rases 
6 . 1 . Forming C-0 bands 
6 . 1 . 1 . Amino acid HNA. l i ga se s 
6 . 3 . Forming C-N bands 
6 , 3 , 1 . Acid ammonia l i gases 
6,1+. Forming C-C bands 
6.if.1« Carboxylases 
Leucine amin©peptidase 
Pepsin, Trypsin, chymo-
t ryps in . 
Pyruvate decarboxylase 
Aldolases 
Fumerate hydrolase 
Hibulose-5-phosphate 
epimerase 
Maleyl acetoacetate i s o -
merase 
Glucose phosphate iscmerase. 
Methylmalonyl CCA mutase 
Amino acid act ivat ing enzyme. 
Glut amine synthetase 
Acetyl COA carboxylase. 
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Each enzyme has a systemic code number (EG) consist ing 
of four d i g i t s . The f i r s t d i g i t ind ica tes c lass and charac-
t e r i z e s the react ion type of the s ix main c lasses of enzymes. 
The second d i g i t represents the subclass , t h i rd d i g i t i nd i -
cates subsubclass and the fourth d i g i t i s for the p a r t i c u l a r 
enzyme named. The f i r s t three d ig i* give a c lear ind ica t ion 
of the nature of the enzyme. Some examples are summarized 
i n Table-1 ( 1 ) . 
D. Tissue s p e c i n c i v / aaa Clii i iual ulKr^ificaace of Eczrises! 
The c l i n i c a l s ignif icance of an enzyme d i r ec t ly corre-
l a t e s with i t s t i s sue s p e c i f i c i t y . Tissue d i s t r i b u t i o n or 
spec i f i c i ty of an enzyme (o r i t s isozyme forms) primarily 
depends on the metabolic demand of the enzyme by the t i s s u e . 
For example the r e l a t i v e t i s sue d i s t r i b u t i o n of Ii)H, and IDH^ 
depends upon the oxygen tension of the t i s s u e , and so LDH^  i s 
predominantly present i n oxygen r i c h hear t whereas IDHt i s the 
dominant form in oxygen poor muscle. Different forms of 
malate dehydrogenase recognised i n mitochondria and cytosol 
play d i f f e ren t metabolic r o l e s . During d i f f e r e n t i a t i o n and 
developoent of adul t t i s sues from t h e i r embryonic one, the 
isozyme pa t t e rn in t i s s u e s changes again because of the 
changing metabolic needs of the t i s s u e . Thus BB isozyme of 
CPK i s predominent in a l l embryonic t i s s u e s ; but the expression 
of the gene for t h i s isozyme i s severely r e s t r i c t e d in adul t . 
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The expression of gene for th i s isozyme in brain i s , however, 
expressed a t a normal r a t e even in adul t . I n myocardium, MM 
and MB isozymes gradually replace BB as the M gene i s expre-
ssed in associa t ion with myof ibr i l la r con t rac t i l e elements. 
Likewise in adult s k e l e t a l muscle, the isozymes MM predominates 
due to increased expression of Mgene. The genes which are 
expressed in foe t a l stage are often expressed in msJlgnancy, 
Thus aldolase A which i s a foe ta l form for l i v e r , reappears 
i n a hepatoma replacing aldolase B, normally present i n adult 
l i v e r t i s s u e . 
Enzymes, spec i f i c for a p a r t i c u l a r t i s s u e , va r ies in 
concentrat ion i n the healthy and diseased s t a t e s of tha t 
t i s s u e . I n t r a c e l l u l a r enzyme concentration es t imat ion r e f l e c t s 
the ac tual extent of injury but on routine bas is such assays 
are not done. Al te ra t ion of serum enzyme leve l i s exploi ted 
as a parameter of sever i ty of c e l l u l a r assaul t as there i s 
re lease of enzymes in the plasma following c e l l damage or 
dea th . Other body f lu ids l i k e C.S.F. , BBC or WBC lysa te or 
u r ine may also be used as the source of es t imat ion. 
In sp i t e of the fac t tha t the attempt of using one 
ind iv idua l enzyme as a simple marker suggestive of any disease 
of a spec i f ic t i s s u e i s y e t t o be fulfilled,tfie epoch-making 
discovery of est imation of serum l ipase in the diagnosis of 
pancrea t i c d i seases in ear ly 19OO A.D. and the importance of 
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AST in myocardial i n fa rc t ion observed by LaDue, Wroblewski 
and Karmin (2) in 195^ have paved the way to exp lo i t the 
serum enzyme leve l as d iagnost ic and prognost ic ind ica to r 
as wel l , in c l i n i c a l biochemistry. The d iseases of l i v e r , 
ske l e t a l muscle, bone and other t i s s u e s can be diagnosed by 
a l t e r a t i o n of some serum enzymes or more prec ise ly the 
isozyme f rac t ion of an enzyme t o sharpen the dieignostic 
i n d i c a t o r . 
thai 
The study ot several enzyme or isozyme ^changes over 
a period of hours or days i s the bes t guide i n t h i s respect . 
Duration of increased enzyme a c t i v i t y i s frequently 
of d iagnos t ic importance. As in case of acute myocardial 
i n f a r c t i on , the changes in enzyme ac t i v i t y with time var ies 
i n a following way; 
Rise begins h hours 12-18 hrs 13-18 hrs 12-18 hrs . 
v l t y **^*^" ^^ ^ ° " ^ ^ ^^ ^^^^ 72 hours 72 hours 
Return to 
normal h days 5 days 7-1O days lO-li* days 
In revers ib ly inflammatory processes , character ised by 
increased membreine permeabi l i ty , c e l l sap enzymes Gire more 
l i k e l y to be released i n t o the c i r c u l a t i o n than are mito-
13 
chondrial enzymes. In necro t ic condi t ion, the reverse occurs. 
The i n t e r p r e t a t i o n of serum enzyme pa t t e rns can be 
d i f f i c u l t i f a disease leads t o enzyme re lease frcan several 
organs. As i n pa t i en t with myocardial i n f a r c t i on complicated 
by heart f a i l u r e , AST r i s e s f i r s t , followed by AU r i s e due 
t o hepatic congestion with heart f a i l u r e . 
The difference in the clearance r a t e s of enzymes are 
widely used d iagnos t i ca l ly . The half l i f e of enzymer. I s 
important t o determine the timing for enzyme est imat ion. 
The base l ine l eve l of most enzymes and isozymes 
r e f l e c t the normal c e l l leakage and c e l l u l a r turn over. 
Increase in l eve l s of enzymes and isozymes i n excess of 
these reference rcuiges are associated with a var ie ty of 
pa thologica l chsinges and are the b a s i s of c l i n i c a l u t i l i t y 
of enzyme and isozyme es t imat ion . 
The normal l eve l of enzyme dex}ends on the assay 
procedure a l so and so the method of assay should be mentioned 
with the normal l eve l of any enzyme. 
£ . Some Cl in ica l ly Tnmortant Enzvmest 
A few c l i n i c a l l y important enzymes with de f in i t e t i ssue 
spec i f i c i ty such as IDH, CPK, Aldolase, ACP and -amylase 
have been described along with'some other d iagnos t ica l ly 
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TABLE 2 : LACTATE DEHXDHOGENASE ACTIVITY - PERCENTAGE ACTIVITY 
DISTRIBUTION IN VARIOUS HUMAN TISSUE ( 2 0 a ) . 
Organ 
. 
Hear t 
Kidney 
Cerebrum 
L i v e r 
Sk. muscle 
S k i a 
Lung 
Spleen 
\ 
60 
28 
28 
0.2 
3 
0 
10 
5 
H3«1 
30 
3^ 
32 
0 .3 
U-
0 
18 
15 
Isozyme 
H2M2 
5 
21 
19 
1 
8 
h 
28 
31 
distributi< 
H^M3 
3 
11 
16 
If 
9 
17 
23 
31 
on 
\ 
2 
6 
5 
9^ 
76 
79 
21 
18 
15 
TABLE 3 : ALDOLASE ACTIVITY IN ViiRIOUS HUMAN TISSUES ( 9 3 > . 
Tissues Isozyme distribution in u/g of wet tissue {,% total activity) 
A B C 
1. Sk. muscle 
2 . Heart 
j . Lung 
h. Spleen 
5. Kidney 
6 . Liver 
7. Small i n t e s t i n e 
8. Cerebrum 
9 . Cerebellum 
19,600 (97) 
2,068 (90-96) 
25H ( yo ; 
if70 (96) 
22lf (IfO) 
1 1 ^ ( l i f ) 
255 (50) 
2125 (70) 
1200 (33) 
0-2Ifl4. (0 -10) 0-26lf (0 -12) 
336 (60) 
700 (86) 
255 (50) 
875 (30) 
2if00 (66) 
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TABIE hi CBEAIIHB PHOSPHOKIHASE ACTIVITY IN VARIOUS HUMAN 
TISSUES (9M-X 
Tissues 
1. Sk. muscle 
2 . Heart 
3 . Brain 
U., Colon 
5. Stomach 
6 , Uterus 
7. Thyroid 
3 . lung 
9 . Kidney 
10, P ros ta t e 
1 1 , Spleen 
12. l i v e r 
13 . Pancreas 
^^•* Placenta 
Isozyme 
MM 
3281 (100) 
313 (78) 
0 (0) 
^ (3) 
h (3) 
1 (2) 
7 (26) 
5 (3^) 
2 (8) 
0.3 (3) 
5 (7^) 
3.6 (90) 
O.if ( i i f ) 
l . if (^8) 
d i s t r i b u t i o n in xx/g 
i% t o t a l a c t i v i t y ) 
MB 
0-623 (0-19) 
56-169 (m-»+2) 
0 (0) 
1 (1> 
2 (2) 
1 (3) 
0.3 (1) 
0.1 (1) 
0 (0) 
O.lf (1+) 
0 (0) 
0.2 (6) 
0 (1) 
0.2 (6) 
of wet t i ssue 
BB 
0 (0) 
0 (0) 
157 (130) 
• -r J V y O > 
nh (95) 
1+5 (95) 
21 (73) 
9 (^V) 
19 (92) 
9.3 (93) 
2 (26) 
0.2 (i+; 
2.6 (85) 
1.^- {k6) 
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TABLE 5: ALKAIII*: PHOSPHATASE ACTIVITY IN HUMAN TISSUES ( 9 5 ) . 
T i s s u e s A c t i v i t y ( u / g of wet t i s s u e ) 
MAP buffer 
30.0 
36.0 
12.6 
I'D 
7.5 
6.6 
if.8 
W.2 
3 0 
2.1 
1.8 
o.oe 
DEA buffer 
66.0 
-
27.0 
18.0 
18.0 
15.0 
9.0 
11.C 
6,6 
5.1 
3.6 
— 
1. Adrenal 
2 . P l a c e n t a 
3 . L ive r 
If, Bone 
5, Spleen 
6 , Lung 
7 , I n t e s t i n e 
8, Kidney 
9 , P r o s t a t e 
1 0 . Thyroid 
1 1 . H e a r t 
1 2 . R.B.G. 
MAP-2-nietliyl-2-aininol-propanol buf fe r DEA-diethylaxnine buffer , 
TABIE 61 TRANSAMINASE ACTIVITY IN HUMAN TISSUES RELATIVE TO 
SERUM AS UNITY ( 9 6 ) . 
T i s sue AST ALT 
1 . H e a r t 
2 . L ive r 
3 . Sk, muscle 
if. Kidney 
5 . Spleen 
6 . lung 
7 . Pancrease 
8 . H.B.C. 
9 . Serum 
78 00 
7100 
5000 
If 500 
700 
500 
m-00 
15 
1 
if50 
2850 
300 
1200 
80 
^5 
130 
7 
1 
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important enzymes with wide t i ssue d i s t r i b u t i o n i n the 
following pages. Tables 2 , 3 , i+, ^, and 6 show the a c t i v i t i e s 
of some of these enzymes in human t i ssues* 
1. L ' l a c t a t e dehydrogenase (EC 1 . l ,1 .27) t 
Ce l l free ex t r ac t s able to catalyze the oxidation of 
l a c t a t e to pyruvate were f i r s t obtained i n 1932(3). The f i r s t 
pur i f ied LDH was reported by Straub ih) i n 19U-0. 
ii, ; i - v , w v a) General p racar^ ies : I t has a molecujiar weign\. u
da l tons containing four subunits of two d i f f e r e n t types (H & M) 
each weighing 35,000 da l tons . 
I t ca ta lyses the revers ib le oxidat ion reduct ion 
reac t ion : 
CH, 
H - COH + NAD 
1 
COOH 
Lactate 
i n the g lyco ly t i c cgrols. 
CH^ 
1 
C = 0 i, NADH + H 
1 
COOH 
Pyruvate 
The optimum pH and temperature of the enzyme are 
7*2 - 9 ,8 and 32 c . The enzyme does not conta in any metal 
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ions (5»6) . No disulphide bridges have been reported for IDH, 
however, each subunit contains one c r i t i c a l cys te in res idue, 
modification of which r e s u l t s i n loss of ac t i v i t y ( 7 ) , 
I t ca ta lyses i ) Ketopyruvate reduction, i i ) Glyoxalate 
oxidation and reduction, i i i ) cyanide addit ion to nicotinamide. 
The equil ibrium constant for the reduction of NAD ^ depends on 
the subs t r a t e . The presence of a coenzyme, NADH-*—*NAD i s 
e s s e n t i a l for the c a t a l y t i c function of LDH. 
' Sulfhydryl group aqppears t o be a pa r t of the active 
s i t e of the enzyme which i s strongly inh ib i t ed by para-chloro -
mercuribenzoate or N>ethtylmalelmlde. Oxalate i n h i b i t s the 
forward reac t ion i n a noncompetitive manner, while the prodout 
pyruvate i n high concentration becomes competitive i n h i b i t o r 
Oxalate ac ts as a competitive i n h i b i t o r i n baclcward react ion. 
I t i s a l so inh ib i ted by l a c t a t e a t a very high concen-
t r a t i o n s . As with most i n h i b i t o r s , the a isozyme (Kj = 26 nM) 
i s more sens i t ive than K Isozyme (K. = 130 mM) ( 8 ) . 
b) Isozymes and t i s sue s p e c i f i c i t y : IDH occurs i n animal 
t i s s u e s as five differene isozymes separable by e lec t rophores i s . 
Each Isozyme contains four polypeptide chains of two d i f fe ren t 
(H & M) types i n d i f f e r en t permutation ( 9 , 10) . 
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The difference In isozyme composition in various 
t i s sues or i n other words the d i s t r i b u t i o n of these two poly-
peptide chains has been correlated to d i f fe ren t metabolic 
requirements and the oxygen concentration of the t i s s u e s 
(10-13) . 
Although there are only two major s t r u c t u r a l genes 
(corresponding to the M & H chains) , there i s a complex 
var ie ty of other IDE genes which can be expressed i n sosne 
tissues^ a t oex^laiu stages ui duvtfxqpmeDt. 
In s k e l e t a l muscle the IDH isozyme tha t predominates 
contains four M chains and i n heart the predooiaant isozyme 
contains four H chains. The IDH isozymes i n other t i s s u e s are 
a. mixture of five poss ib le forms, which may be designated as 
Mi^ , M^H, M2%» MH j^H^ or IDH^, IDE^, LDH ,^ LDH2 and IDtt^ 
r e spec t i ve ly . IDH X i s an isozyme coded by C gene present i n 
mammalian t e s t i s . 
For a l l p r a c t i c a l purposes, considering the incidence 
of d i seases of d i f fe ren t systems, LDH isozyme can be cons i -
dered as t i s sue speci f ic and thus helpful i n clird-cal d iagnosis . 
The major l oca l i za t ion of various isozymes i s shown 
i n Table 7 . 
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TABIE 7 : MAJOR LOCALISATION OF VAHIOUS LDH ISOZ:£MES, 
LDH^ 
Hear t 
RBC 
HE system 
Kidney-
Cortex 
IX»H2 
RBC 
RE sys tem 
K i d n e y -
Cortex 
Lung 
LDH3 
Lung 
P l a c e n t a 
L D \ 
Kidney-
Medul la 
Sk. muscle 
P ancre as 
P l a c e n t a 
li^H^ 
L i v e r 
Sk. muscle 
Panc rea s 
Kidney-
Medul la 
TABLE 81 CLIICiCAL GOICITIONS ASSOCIATED WITH EIEYATED SERUM IDH 
LEVEL. 
IDH Isozymes C l i n i c a l c o n d i t i o n s 
IDH-, and IDH2 
LDH .^ and LDHt 
UDHg, IDH^ and LDH^ ^ 
Haemolysis , Myocsirdial i n f a r c t i o n , 
Renal c o r t e x i n f a r c t i o n , some 
tumours. 
H e p a t o c e l l u l a r damage ( n e c r o s i s , 
in f l ammat ion , c o n g e s t i o n ) , s k e l e t a l 
muscle t r auma , Crush i n j u r y . 
M a l i g n a n c i e s , e s p e c i a l l y leukemias 
and lymphomas. Lung Disease and 
c o n g e s t i o n . 
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The isozymes are d is t inguishable by t h e i r chemical 
composition and t h e i r k ine t i c and immunological p rope r t i e s . 
At pH 8 ,6 , the e l ec t rophere t i c mobility of LDH, i s 
highest while t h a t of IDH^ i s lowest and remains near o r ig in . 
Other isozymes remain in between. 
The tteat s t a b i l i t y of IDE isozymes are of d iagnos t ic 
importance. LDH,- i s heat l a b i l e a t 65*^ C for 3O minutes i n 
contras t t c heat s t a b i l i t y of IDE.* 
LDH^  has a low K for pyruvate and i s strongly i n h i -
b i t ed by pyruvate whereas LDH^  has a higher Km for pyruvate, 
i s not inh ib i t ed by pyruvate and i s more active c a t a l y t i c a l l y . 
c) C l i n i c a l s igni f icance; LDH isozyme f rac t ion i s most useful 
for ru l ing out myocardial damage and muscle injury occasionally 
for monitoring progression of ce r t a in malignancies. 
The normal serum l e v e l of LDH by Henry* s L-P (1^+) 
method i& 63-155 U / L in male, 62-131 U/L i n female and 
chi ldren having 10-15^ higher value. Among t h i s IDH^ - 18-33^, 
LDHg - 28-lfqC, LDH^  - l8-3C^, IDHi^  - 6-l6{^, LDH^  - 2-13Jt. 
Some of the c l i n i c a l conditions associated with e leva-
t ions of d i f f e r en t LDH isozymes are summarized i n Table 8, 
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2 , Creatl7\e phosphoklnase (EC «2,7.3*2); 
. Creatinine phosphokinase was f i r s t c ry s t a l l i z ed from 
rabb i t ske l e t a l muscle (15)» I t has a lso been i so l a t ed i n 
pure form from a number of sources. 
a) General P roper t i e s ; I t has a molecular weight of 80,000 
dal tons containing two subunits each weighing U-OjOOO da l tons . 
I t ca ta lyses the revers ib le phosphate t ransfer from crea t in ine 
phosphate t o adenosine diphosphate. 
2 - PH -9>0 2 - - ^ 
Creat inine + Mg ATP IZZZZZ^ Phosphocreatinine •»• KgADP ^ 
pH - 6.b 
I t s p t ^ s i o l o g i c a l role i s associated with ATP generat ion for 
con t r ac t i l e or t ranspor t systems. 
The optimum pH and temperature of the enzyme are 
6.8 - 9 and 25^c r 37°C respec t ive ly . 
The amino acid compositions of MM & BB types are not 
very d i f fe ren t ^nd the BB type contains s ign i f i can t ly l e s s 
of the bas i c andno acids than the MM forms explaining the 
g rea te r e l ec t rophore t i c mobi l i ty . Amino acid composition 
of MB form i s intermediate between the two parent forms. I t 
i s a t h i o l enzyme and each subunit contains one c a t a l y t i c 
s i t e . The r e a c t i v i t y of e s s e n t i a l t h i o l group i s closely 
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l inked t o the conformational changes t h a t occur when both 
subs t ra tes are bound to the enzyme. 
2 + ^2 -& +2 
For the rabbi t muscle enzyme Mg , Mn , Ca and CO 
have been found to act as ac t iva to r s while Ba % Sr , Be % 
Ni^*, Cr^% Cd^* and Zn^ "*" were i nh ib i to ry (16) . Anions such 
-2 - -^ 
as Soj^  , CI and PO^ ."^  a l l acted as competitive i n h i b i t o r s of 
the enzyme for phosphocreatinine and non competitive i nh ib i -
t o r s for Mg ADP (17)« 
b) Isozymes «,qd ti^ssue spec i f i c i tvs GPK occurs i n animal 
t i s s u e s as three d i f fe ren t igogymes separable by e l e c t r o -
phores i s (18-20) • Each isozyme i s a dimer composed of two 
non- ident ica l mcxiomeric subuni t s , M axid B. The enzyme i s 
found primari ly in s k e l e t a l muscle (maximum concentration) ^ 
cardiac t i ssue and bra in . Although the majority of isozymes 
are cytoplasmic, i t may a lso be present i n other subcel lular 
f rac t ion p a r t i c u l a r l y mitochondrion. Isozymes of CPK exhibi t 
t i s sue s p e c i f i c i t y . Thas the isozyme MM i s the predominant 
form in human s k e l e t a l muscle although a small amount i s 
a l so found i n hear t in which t i s sue the predcaninant form of 
the enzyme i s MB. A small amount of CPK-MB i s a lso present 
i n ske l e t a l muscle. The isozyme BB i s found primari ly in 
b ra in t i s sue and t o a smaller ex ten t i n G . I . t r a c t . 
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Developmental s tudies show that the BB form i s predo-
minant in a l l ear ly embryonic t i s s u e s . However, a t adult 
s t age , the expression of the gene for BB i s r e s t r i c t e d and 
i s associated primari ly with the bra in and some gut associated 
t i s s u e s . 
The various forms of isozymes can be separated by 
e l ec t rophores i s , ion exchange chromatography and immunological 
techniques. 
The anodic mob i l i t i e s of the various forms of enzymes 
a t pH 8.6 were found to follow the order BB > MB > MM. Infact 
the movement of isozyme MM a t pH 8.6 i s hardly pe rcep t ib l e . 
c) GUnical Signif icance; Serum CPK i s increased i n nearly 
a l l p a t i e n t s , when there i s in jury , inflammation or necrosis 
of ske l e t a l or hear t muscle (20 ) . Decreased leve l of the 
enzyme i n human serum has l i t t l e or no c l i n i c a l s igni f icance . 
The normal serum values of CPK by B MD GK-NAC method (20a) i s 
upto 160 U / L i n males and upto 13O XJ/L in females. Blacks 
tend t o have higher values than white. Serum l e v e l can be 
increased by exe rc i se . Well muscled indiv iduals have normal 
CPK l e v e l , t ha t i s higher than those of small sedentary person. 
The isozyme d i s t r i b u t i o n in the serum of normal ind iv idua l 
form one morith to adult age i s MM - 96-IOC5S, MB - h% and 
BB - OS. 
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TABI£ 9; CLINICAL G01©ITI0NS ASSOCIATED WITH EIEVATED SEHUM 
CPK LEVELS. 
CPK Isozymes Cl in ica l condit ions 
CPK - MM Extreme physical exer t ion, 
physical and surgica l trauma, 
Intramuscular i n j e c t i o n s , 
Rhabdqmyolysis, Malignant hyper-
pyrexia IMM, BB). MycpatJiles except 
dernervat ion myopathy (MM, MB), 
ce r t a in in fec t ious d iseases tha t 
affect muscle. 
CPK - MB Myocardial i n f a r c t i o n , muscular 
dystrophy espec ia l ly Ducher^-ne's 
type , Polyagositis. 
CPK - BB Malignancy, p r o s t a t i c , pulmonary 
and neurological d i s o r d e r s . 
CPK - Hypothyroidism, SchizophJrenia, 
myocardi t i s , p e r i c a r d i t i s , coma^ 
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Some of the c l i n i c a l condit ions associated with tlie 
e leva t ions of d i f f e ren t CPK isozymes are summarised i n Table 9 . 
3 . hl<XQlsS9 (EG " ^ - . I . S t n ) . 
In 193^ Meyerhof and Lohmann discovered the revers ible 
cleavage of hexosediphosphate t o form 2 moles of dilqrdroxy-
acetone phosphate, catalysed by an enzyme which they ceQled 
zymohexase (21) . They l a t e r renamed i t aldolase when they 
found t h a t I t would catalyse the revers ib le condensation of 
dihydroxy ace tone phosphate with a var ie ty of aldehyde (22,23) , 
Aldolase was c rys t a l l i z ed from r a t muscle by Warburg and 
Chr i s t i an (2l+). 
a) General Prooer t iess I t has a molecular weight of ^proxima-
te ly 160,000 da l tons , containing four subunits , each having a 
molecular weight of ^•0,000 da l tons . 
I t ca ta lyses the revers ib le reac t ion : 
EC ^ . 1 . 2 . 1 ^ . 
Fructose-16 diphosphate -r dihydroxy ace tone •*• 
(FDP) Glyceraldehyde-3-
phosphate. 
The optiimm pH and tenderature of the enzyme are 
6.8-7.2 (25) and 37^0^ r e spec t ive ly . Class I aldolases do 
not require metal ion as cofactor while c lass I I aldolases 
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require i t . Molecular weight and subunit s t ruc ture of 
aldolase A & B are almost s imi la r (26, 27 ) . The amino acid 
composition and sequence a t the act ive s i t e of the three i s 
c losely homologus though they d i f f e r s ign i f i can t ly in the 
o ther regions of the molecule. 
Aldolase B d i f f e r s i n c a t a l y t i c and immunologic 
p rope r t i e s from aldolase A (27-29) whereas c a t a l y t i c property 
of aldolase C I s found t o be s imi la r t o t h a t of a ldolase . 
Antibodies prepared against each type of subunit i s specif ic 
and does not cross reac t wi th the other type (28 ) . Mononers 
i n the hybrid forms act independently without subunit i n t e r -
act ion and antibody against one subunit i n a heteropolymer 
can cause t o t a l i n h i b i t i o n of the te t ramer ic enzyme. 
Aldolase B i s i nh ib i t ed by AMP > ADP but not by by ATP 
whereas aldolase A I s competitively inh ib i t ed by a l l three 
nucleot ides , the order being ATP > ADP > AMP. Aldehydes also 
i n h i b i t the enzyme. 
b) Isozyme and t i s sue spec i f i c i t y : Two c lasses of aldolases 
are p resen t . Glass I a ldolases which form schiff h&se i n t e r -
mediate with the s u b s t r a t e , aire widely d i s t r i b u t e d in mammals 
euid higher plsuits . Class I I a ldolases are metal loaldolases 
and do not form schiff base and resemble yeas t aldolase 
present i n yeas t , b a c t e r i a and fungi . 
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Rutter and his co-workers (30-3^) have iden t i f i ed three 
d i s t i n c t aldolase isozymes based on t h e i r e l ec t rophore t i c proper-
t i e s fDP/FIP ac t iv i ty r a t i o s and i nh ib i t i on yby speci f ic a n t i -
bodies i n t i s sues of mammals and other ve r t eb r a t e s . 
I t i s a tetramer composed of two of three known sub-
u n i t s designated as A, B and C. Aldolase A i s the major form, 
usual ly the only form present in s k e l e t a l muscle. Aldolase B, 
the predcninant form i n l i v e r and kidney, aldolase C i s 
"present l a Drain together v i t b aldolase A. In ti«!5»7es vWoT*e 
more than one aldolase isozyme i s p resen t , hybrid forms composed 
of subunits of both primal? forms sire a l so found to be present* 
The l^rbrid isozyme composed of three A subunits and one C 
subunit i s present i n low concentration i n serum as the primary 
isozyme in normal serum i s a homomer. Aldolase A i s primari ly 
p resen t i n s k e l e t a l muscle and to some ex ten t i n hear t and 
b r a i n . Aldolase B i s mainly present in l i v e r and a small 
amount i n kidney and small i n t e s t i n e . Brain i s the predominant 
source of a ldolase , though a small amount i s a lso present i n 
h e a r t . When analysed as homotetramers, aldolase A, B, C 
AiLdplftse A AAcl9la?? S Aldolase C 
Stoeletal muscle l i v e r Brain 
Heart Kidney Heart 
Brain Small I n t e s t i n e 
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have s imi lar pH a c t i v i t y p r o f i l e s , K for FDP and molecular 
weights. The r a t i o of the FDP/F-IP cleavage ra te i s respec-
t i v e l y , 50 for aldolase A, 1-2 for aldolase B and 26 for 
aldolase C. Aldolase A i s usual ly present i n a l l the human 
embryonic t i s s u e s , which are replaced subsequently af ter 
b i r t h . The t r a n s i t i o n form A t o B occurs ear ly in l i v e r 
(Before day 55) an<i l a t e r i n kidney (3®). Aldolase G begins 
to api)ear in human b ra in a f te r day 100. Human embryonic heart 
mupole contains aldolase A and C together with li^bria forms; 
Traces of these hybrid forms p e r s i s t i n adult l i f e . 
c) C l i n i c a l significanoes Though not frequently measured, 
i t has a de f in i t e s ignif icance i n some sloeletal muscle 
d i sorders (33)fc)« The normsil serum leve l of aldolase by the 
method of Bergmeyer and Bernt (20a) i s 2.61-5.7I D / L in males 
and 1.98-5.5^ U / L i n females. The chi ldren has twice the 
adult l e v e l . 
Aldolase l eve l i s mainly increased i n ske le t a l muscle 
d isorder except denervation myopathy and mesthenia group 
(a ldolase A), l i v e r necros is (a ldolase B) , myocardial 
necrosis (a ldolase A), hepatoma (a ldo lase A) and haemolysis 
(3^, 35). 
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^* Acid Phosphatase (E,G. - ^.U^.2): 
In 192 -^ Martlarxi e t sil. (36) reported phosphatase acti? 
vi t^ i n RBC. While studying the source of acid phosphatase 
ac t iv i ty i n male u r i n e , Kutscher and Wolberg discovered the 
very high ac t iv i ty of AGP i n human pros ta te (37) • 
a) General P roper t i e s ; I t has a molecular weight of about 
100,000 dal tons but var ies considerably with isozymes. I t i s 
nai spec i f ic phosphatases t ha t catalyse the hydrolysis of 
orthopho9pboric mono e s t e r to an aiconol and phosphaU? ^ruup 
a t an acid pH. 
R^-0-P0^H2 •<• H-OH ^^ > R -^OH + H-O-PO^Hg 
organic phosphate alcohol phosphate 
e s t e r alcohol (new) ( e s t e r new) 
The pptlmum jE ranges from U-.8-6,0 depending on t i s sue source 
and subst ra te used. Optimum temperature i s 37°G. 
Phosphoryl t ransfer may be effected by p r o s t a t i c AGP 
to acceptors other than solvent (38-4-0). I t i s very sens i t ive 
to^-surface-it iactivation, A var ie ty of agents g e l a t i n , BSA^ 
egg albumin and tween-80 p ro tec t the enzyme aga ins t i nac t lva -
t i o n . I t i s inh ib i ted by alpha hydroxy carboxyllc acid and 
a l so by f luoride a t a r e l a t ive ly low concentra t ion. P r o s t a t i c 
AGP i s p a r t i a l l y and reversibly inac t iva ted by Ga^^ ion. 
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Anions such as ch lor ide , bromide and thiocyanate i n h i b i t 
p r o s t a t i c AGP a c t i v i t y both competitive and non-competitively, 
Behrendt (M) shows that RBG enzyme i s much more active 
than serum AGP i n s p l i t t i n g phenyl phosphate. RBG AGP s p l i t s 
ne i ther alpha nor beta naphthyl phosphate. Different metal 
ions show differences in inh ib i t ion between RBG and p r o s t a t i c 
AGP. 
b) Isozymes atiu txaauc oi.'g>, • f l c i t y ; Ublag dla^ o-crylsmide 
e lec t rophores i s of serum at pH 5» d i f f e r en t baMs have been 
found and named as AGP , AGP^, ACP2, -^ GP j^ ^GP^^ ,^ ACPj^  and 
ACP^ according to t h e i r r e l a t i v e mobility i n the e l e c t r i c 
f i e l d . 
AGP i s p resen t i n very high concentration i n pros ta te 
RBG, WBG, p l a t e l e t and t o a l e s se r ex ten t i n l i v e r , spleen, 
bone, kidney (^-U-7). I t i s a lysosomal enzyme. Gl lnical ly 
i n most cases , highly ra ised leve l of AGP ind i ca t e s advanced 
stage of p r o s t a t i c malignancy, haemolysis or p l a t e l e t des t ruc-
t i o n . Thus i t i s mainly spec i f i c or p r o s t a t e , HBG and p l a t e -
l e t . Tissue spec i f ic isozymes can be d i f f e r en t i a t ed by assaying 
the enzyme i n following manner (1+8-50). 
The a c t i v i t y of isozymes from pros ta te l i v e r , kidney 
and spleen i s subs tan t i a l ly inh ib i ted {70^9%) by L - t a r t a r a t e . 
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The p r o s t a t i c , sp lenic , hepatic and rena l isozymes are 
not inhib i ted by formaldehyde which i n h i b i t s isozyme from RBC. 
Ethanol i n h i b i t s p r o s t a t i c and RBG AGP but not AGP from l i v e r 
and spleen. The p r o s t a t i c AGP ac t i v i t y can be spec i f i ca l ly 
monitored using a new substrate namely thymoiphthalein mono-
phosphate. This method i s used in the diagnosis of p r o s t a t i c 
diseases (51)« 
The isozyms pa t t e rn of AGP i n various organs show signi-
f icant d i f ferences . As ?n«nv as twenty d i f f e r e n t isozymes have 
been reported ( 5 ^ - 53) clue to heterogeneity i n carbohydrate 
por t ion of molecule. 
Of these isozymes, only p r o s t a t i c AGP (ACP21 PAP) and 
isozymes 1 and 5 from human spleen have been used for c l i n i c a l 
d iagnos is . The elevated l eve l of isozymes 1 and 5 i n human 
spleen i s suggestive of Gaucher* s d i sease . 
I n the serum, the contr ibut ion of AGP a c t i v i t y comes 
from p l a t e l e t and BBC mainly and to a lower extent from 
p r o s t a t e . 
c) C l i n i c a l s ignif icanoe: The normal l e v e l of the enzyme i s 
1-3.5 KA/dl by the method of King and Jegatheesan (101). 
P r o s t a t i c AGP l eve l i s usual ly l e s s than 0,8 KA/dl. A 
phys io logica l e levat ion of t h i s enzyme occurs i n childiren 
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and during pregnancy. Determination of serum PAP i s an useful 
procedure primari ly in the assessment of carcinoma of pros ta te 
with or without metas tas is (53+-57)« PAP f rac t ion i s a lso 
increased in p r o s t a t i c in fa rc t ion and operative trauma to 
p ros t a t e (58 ) . In id iopa th ic thrombocytopenic purpura serum 
AGP may be increased (59, 60) . 
Gaucher*s d i sease , Niemann pick d i sease , various bone 
d iseases such as Paget* s disease (61) , metas ta t ic carcinoma 
of bone, mult iple myeluma iucsy ue associated v^'.n ralst^ji .i-^c 
Rarely AGP may be elevated i n H v e r and kidney d i sea se s . The 
de tec t ion of high a c t i v i t i e s of AGP i n vaginal washings i n d i -
cates the presence of seminal f lu id . Decreased serum AGP 
has no c l i n i c a l s ign i f icance . 
5. Alpha Amylase (E.G. - ^ . 2 . 1 . 1 ) ; 
Alpha amylases were named by Kuhn (62) because the 
hydrolyt ic products possess the alpha configurat ion. The 
p re f ix alpha or b e t a conveys information about product 
streocheroistry not substrate spec i f i c i t y . 
a) General Proper t les t I t has a molecular weight of ^-0,900-
50,000 da l tons . I t degrades complex carbohydrate molecules i n to 
smallercomponents. Human amylases are alpha ao^lases . They 
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are endo-amylases and hydrolyze the i n t e r n a l 1,14-glycosidic 
bonds of polysaccharides In a random manner. 
The optimum pH and temperature of the enzyme are 7 and 
37-^0°C respec t ive ly . The diffusion coeff ic ien t and p a r t i a l 
spec i f i c volume of pancreat ic and sa l ivary enzymes are almost 
s i&i la r . There are minor changes i n the amino acid coniposition 
of these p r o t e i n s . 
I t i s a metal lo enzyme as i t contains Ca "*" (63-65) . 
I t s removal r e s u l t s i n both revers ib le (63 , 6J+) and i r r e v e r -
s ib l e i nac t i va t i on or i n great loss of thermal s t a b i l i t y . 
Ca '*' de f i c i en t amylase i s found t o be suscept ible t o protease 
d iges t ion (67) . Ca"*"*" s t a b i l i z e s the canpact a rch i tec ture of 
the molecule and i t helps to maintain an enzymatLcally active 
conformation (614-), Ca and Mg are ac t iva to r s a t low concen-
t r a t i o n but become i n h i b i t o r s a t high concentrat ion ( > IO nM). 
KDTA i n h i b i t s about 9Qji of enzyme a c t i v i t y . Hallde ions are 
required for enzyme a c t i v i t y . The order of t h e i r e f fec t iveness 
i s CI > Br > I > F. feavy metals (63) l i k e mercury, s i l v e r , 
copper and lead i n h i b i t amylase. Ammonium molybdate and ascorbic 
acid (63,66) a lso i n h i b i t amylases. I t i s speculated t o be 
due to sulfhydryl modification (67a) . 
la) Isozymes and t i s sue spec i f i c i t y : The enzyme i s present a t 
i t ' s highest concentration i n pancreas and sa l ivary gland and 
r» 
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can be considered specif ic of these t i s sues . Other t i ssues 
such as l i v e r , fallopian tubes, certain tumours and skeletal 
muscle also contain amylase (68-7O) to a minor extent* 
I t has been found that l iver i s the major source of 
serum amylase (71); though the t issue origin of amylase in 
normal serum i s s t i l l detectable. 
Amylases from a given orgsoi in different species often 
display greater similarity in their enzyme behaviour than 
amylases from different orgsuas of the same species . The 
salivary pancreatic and serum amylases aZso di f fer e l ec trc -
phoretically (72,73) . At l e a s t seven bands can be found on 
electrophoresis from human tissue sources of the enzyme. 
Since the amylases from diverse sources have the same appro-
ximate molecular veight and are dimeric hydridiztlon of two 
genetically controlled monomers i s hypothesized to explain 
the three bands, usually observed In mai^ higher animal 
species (7^)* On electrophoresis of serum amylase, three 
slower moving bands are identif ied as pancreatic amylase 
(P^-P^) and three faster moving bands are ident i f ied as 
salivary amylase (S . -S^) . S^ j und P^ Isozymes are most 
c<»imonly present In the population. Pancreatic amylase i s 
more heat sensit ive than the normal serum amylase. 
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c) C l in ica l a ignif icance; The normal l eve l of alpha amylase 
i s l e s s than 1500 u / l i n serum and l e s s than 5OO \i/2»+ hoars 
i n urine by iodometric method of caraway and Wendell (102). 
I t i s p r inc ipa l ly measured for the diagnosis of acute 
p a n c r e a t i t i s . I t i s a l so elevated i n some other conditions 
l i k e parot id gland d i sease , mumps, p a r o t i t i s , c a l cu l i i n 
paro t id duct , perforated pep t ic u l c e r , i n t e s t i n a l obstruct ion, 
rena l f a i l u r e , ec topic pregnanqy, macroamylasemia, haemolysis, 
spasm of sp lnc te i of oddi by drugs l i k e morphine and codeine, 
chronic l i v e r d i sease . 
6. Trm f^inilnftfffist 
a) fiffl^raJ. Frop?rtt?8» 
i ) A.?partatf^  aBlq<?^yapsf?rag^ (fit£t. 2 ,6 ,1 ,1 , ) ; i t i s an 
enzyme tha t ca ta lyzes the t r ans f e r of an amino group from 
spec i f ic amino acids (L-glutamate or L-aspar ta te) t o specif ic 
keto-acids (Alpha ketc^luteu^ate or oxalo a c e t a t e ) . I t hsis a 
molecular weight of 110,000 da l tons containing two subunits of 
equal s i z e . The optimum -pEL and temperature of the enzyme are 
7.lf and 37°C respec t ive ly . The reac t ion catalyzed by AST i s 
freely revers ib le and has an equi l ibr ium constant of about 1.0, 
AST 
L-Aspartate -focKetoglutarate ** Oxaloacetate + Glutamine 
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AST has pyridoxal phosphate as I t s prosthetic group 
(coenzyme) which i s responsible for carrying the amino group 
via Sch i f f ' s base formation. Although at phyrlological pH 
the reaction i s energetically favoured toward the formation 
of L-asp art ate and cTC-ketoglutarate ( to the l e f t ) , in vivo 
the reaction goes to the right to provide a source for ni tro-
gen of the urea cycle . The glutamate thus produced i s deaminated 
by glutamate dehydrogenase resulting in ammonia and regenera-
t ion of oC-Ketoglutarate. 
The greatest amount of AST i s present in the cardiac 
t issue followed by l e s ser amounts in l i v e r , s k e l e t a l muscle 
suKl kidney. A smedl amount i s present i n the pancreas, spleen, 
lung, erythrocytes, skin and serum. Despite wide t issue d i s t i i -
bution, AST i s usually speci f ic of heart and l i v e r . I t i s 
present i n both the mitochondria and cytoplasm of the c e l l . 
Various observers have discrened that species differences 
are present (33a). 
( i i ) Alanine furrlnotransferase (E.G. 2 . 6 . 1 . 2 . ) : I t i s an 
enzyme that catalyses the transfer of an amino group from 
spec i f ic amino acids (L-glutemate or L-Alanine) to specif ic 
keto acids ( o(-ketoglutarate or pyruvate). 
39 
I t has a molecular weight of 180,000 da l tons . The 
Gptlmum pE and tenperatare are the same as found for AST. The 
subst ra te s p e c i f i c i t y , coenzyme and mechanism of reac t ion are 
same as i n AST except tha t one of the amino acids i s L-Alanine 
instead of L-aspartate and one of the ketoacids i s pyruvate 
ins tead of oxaloacetate . 
ALT 
L-Alanine + oc-ketoglutarate "* Pyruvate ••• L-glutamate, 
Here a l so the chemical equil ibrium favours xjae r eac t ion to the 
l e f t . I n vivo t h i s react ion goes t o the r i g h t to provide a 
source of ni t rogen for urea cycle . The pyruvate thus generated 
i s avai lable for entry i n t o TCA cycle , whereas the glutamate 
i s deaminated y ie ld ing ammonia and alpha ke tog lu t a ra t e . 
ALT i s found in g rea te s t amounts i n l i v e r with 
l e s s e r amounts i n kidney, hea r t and various other t i s s u e s . 
P r a c t i c a l l y i t can be regarded speci f ic for l i v e r . I t i s a 
cytosol ic enzyme. Species d i f ferences have a lso been noted(33|0 
b) Isozymes: E lec t rophore t ic separat ion of serum as wel l as 
l i v e r and hear t muscle AST on paper usually shows the enzyme 
a c t i v i t y i n two f rac t ions (75>76). Separation on stsirch gel 
s^pears to y ie ld two to f ive components (77 ,78) . 
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The main dist inct ion appears to be between tbe (^to-
plasmic enzyme and the mitochondrial enzyme (79-83)• They 
d i f fer in physical and chemical properties and amino acid 
sequence. The isozymes are not organ spec i f ic i8h). The 
c l in i ca l usefulness of the study of th i s isozyme i s not so 
well established. 
c) Clinical significances The normal serum values range from 
5-20 i u / 1 and 5-15 i u / l for AST and ALT respectively by the 
method of Reitman and Frankel (99)* The ccnmonest causes for 
raised serum transaminase l eve l s are heart and l i v e r diseases. 
AST leve l r i ses in acute myocardial infarct ion but not in 
angina pectoris (85)86). Persistent and recurrent elevation 
of AST indicates extension of in farct . A value above 15OO I U / L 
i s a bad prognostic sign. A ratio of AST/ALT i s helpful i n 
determining the source and aetiology of transaminase elevation. 
In myocardial disease i t i s greater than 1, while i t i s l e s s 
than 1 in hepatic disease. Both AST and ALT are elevated in 
l i v e r damage such as occurs in neoplast ic , inflammatory or 
degenerative lesions* 
In acute hepat i t i s , AIT l e v e l i s greater than AST. In 
severe toxic necrosis of l i v e r or severe v i ra l hepat i t i s , AST 
l eve l i s much greater thsin AliT. In c irrhosis of l i v e r , 
moderate r ise of AST occurs. 
n 
AST l eve l I s a lso elevated In Infec t ious mononucleosis 
dermatonyosi t is , renal and pulmonary In fa rc t ion , burn and 
shock. 
7* Alkaline phospha t^e (E.G. ^. 1.3.1 »^ 
The nonspecific phosphatases tha t e f fec t the hydrolysis 
of phosphomonoesters t o alcohol and inorganic phosphate a t an 
a lkal ine pH are designated as a lka l ine phosphatase. 
a) General P rope r t i e s : I t has a molecular weight of about 
120,000 dal tons but var ies considerably with t i s sue source of 
enzyme. The optimum pH ranges from 8•6-10,3 depending on the 
type of subst ra te (87 ) , the subs t ra te concentrat ion, incubation 
temperature and the t i s sue source of the enzyme (88 ) . The 
optimum temperature i s 37°C. 
The enzyme ca ta lyses the r e a c t i o n : -
B^ - PO^ * ^ 0 ^ \ m^^^ > R - OH ^PO. 
1 «+ ^ pa o.D Mg2 Alcohol Inorganic phosphate 
Phosphononoester 
I t can act as phosphotransferases too . I t s a c t i v i t y i s 
dependent on Mg "*" for ac t iva t ion but i s i nh ib i t ed by Ca"*^  (89) . 
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and phosphate ions (89) . Glucose and glycerol increase the 
a c t i v i t y by acting as phosphate acceptors (89) . Diminution of 
ac t i v i t y with oxalate (89) , c i t r a t e (89) and EDTA (89) may be 
42 due to Mg chelat ion by these agents . 
Ammonium hydroxide, borate or glycine based buffers 
have an inh ib i to ry ef fect on the enzyme a c t i v i t y , whereas in 
2-amino-2-methyl-l-propranol buffer s ign i f ican t ly higher 
a c t i v i t y was found (89) ; 
b) ISWYBeg aftj^  ttggttg 3P?g3-figitY?" isozymes of AIP from 
bone, l i v e r , i n t e s t i n e , p l acen t ra and kidney have been i d e n t i -
f ied i n the blood of ind iv idua l p a t i e n t s . Began and Nagao type 
of AIP were discovered i n the sera of ce r t a in percentage of 
cancer p a t i e n t s . The Regan and Nagao type of isozymes az^ 
very sdmilar to p l acen ta l type AIP in physicochemical and 
immunological p r o p e r t i e s . 
E lec t rophores i s , d i f f e r e n t i a l heat s e n s i t i v i t y and 
d i f f e r e n t i a l chemical i nh ib i t i on are current ly the methods 
of analys is most ccanmonly used. Both l i v e r and i n t e s t i n a l ALP 
are moderately heat s table a t ^^C for 15 minutes. I n t e s t i n a l 
AIP i s inh ib i t ed by phenyl alanine unl ike l i v e r ALP. P l acen ta l , 
Regan and Nagao type of ALP are heat s table at ^6^0 for 15 
minutes and a l so inh ib i t ed by pher^rl a lanine . Bone AIP i s 
heat l a b i l e and not inh ib i t ed by phenyl a lanine . Normal 
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l i v e r ( l i v e r I ) isozyme migrates f a s t e s t while bone and 
i n t e s t i n a l isozymes migrate progressively slower. The 
e lec t rophore t i c de tec t ion of t i s sue source of serum isozymes 
in various c l i n i c a l s t a t e s has not been successful (90)• 
I n t e s t i n a l and l i v e r I I isozyme ( i n t r a c e l l u l a r ) are not 
normally present i n serum. Regan isozyme i s produced by 
neoplas t ic c e l l s such as bronchogenic carcinoma, ovarian 
tumour e t c . 
I n s p i t e of wide t i s sue d i s t r i b u t i o n , the enzyme i s 
mainly spec i f i c of l i v e r and bone. I n growing ind iv idua l , 
i t i s present i n g rea te s t concentrat ion i n the bone. I n the 
adul t , l i v e r and i n t e s t i n e contain the l a r g e s t amount of 
enzyme. Kidney and lung a l so have a large amount of enzyme. 
Other s i t e s are p lacen ta , vascular endothelium, b i l e duct , 
epi thel ium, thyr<rf.d epithelium and per iphera l blood. The 
enzyme i s present on the c e l l membrane. 
c) C l in ica l s igni f ieance : The normal l eve l i s 3-13 KA/dl by 
the method of Kind and King (100). A physiological increase 
in the leve l occurs i n growing chi ldren and during 2nd and 
3rd t r imes te r of pregnancy. Men usual ly have a higher value 
than women. The common causes of i t ' s e levat ion are e x t r a -
hepatic b i l i a r y obst ruct ion and ostecnnalacia of bone or other 
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o s t e o b l a s t i c bony l e s i o n s . The bone AIP wi l l increase in 
growing chi ldren , secondary hyperparathyroidism, os teoblas t ic 
me ta s t a s i s , Page t ' s disease and healing bone f r ac tu re . 
Liyer ALP i s noted i n e x t r a and in t r ahepa t i c cho les t a s i s . 
Common causes of ra ised l i v e r AIP are c i r r h o s i s , metas ta t ic 
l i v e r , space occupying les ion of l i v e r . P lacen ta l AIP i s noted 
during pregnancy* The tumour (fiegan) enzyme can be seen in 
malignancy ( 33 ) • 
I n t e s t i n a l AU? i s seldom found i n large amount i n pep t ic 
u l c e r and u lce ra t ive c o l i t i s ( 9 1 , 92) . Similarly splenic 
d i s eases , rena l and pulmonary i n f a r c t i on may give r i s e to 
e levated l eve l of respect ive t i ssue isozymes. 
Pa thologica l conditions causing t i s sue damage r e s u l t 
i n the re lease of c e l l u l a r enzymes i n the c i rcu la tory system 
(9^)* The elevated leve l of the serum enzymes tha t are speci-
f i c for a p a r t i c u l a r t i ssue w i l l obviously have a great 
d iagnos t ic value for the study of the pathology of that 
t i s s u e . Unfortunately i t i s not always poss ible to estimate 
the enzymes in human t i s s u e s . However, as various metabolic 
p a t t e r n s of mammalian systems do not d i f f e r subs tan t ia l ly at 
l e a s t q u a l i t a t i v e l y , ex t rapo la t ion of da ta on enzyme l eve l s 
obtained from t i s s u e s of other mammals can be e x t r ^ o l a t e d to 
human. As the c e l l u l a r l eve l s of enzymes c r i t i c a l l y depend, 
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among o thers , on the l e v e l s of t i s sue pro te iaases and t h e i r 
i n h i M t o r s , i t w i l l be advisable t o determine these parameters 
along with the concentrat ion of enzymes. For comparison, 
normal values of serum enzymes must be determined on s t a t i s -
t i c a l l y adequate saiQ)le size of a given population. Since the 
normal values of serum enzymes usual ly shotf strong dependence 
on n u t r i t i o n a l s t a t u s , age, sex and e thnic groups, t h e i r 
determination i n a p a r t i c u l a r populat ion w i l l be useful 
espec ia l ly i n a country l i ke Ind i a where these values change 
s ign i f i can t ly from one populat ion group to another. In view 
of these cons idera t ions , we have determined the l eve l s of 
t ransaminases, a lkal ine phosphatsise, acid phosphatase and 
amylase in t i s sues of goat buffa lo , r abb i t and human. The 
normal l eve l s of these enzymes i n blood samples of Aligarh 
populat ion were inves t iga t ed . The sample size chosen i n t h i s 
study comprises of two hundred inv id idua ls of d i f fe ren t age 
and sex. The r e s u l t s along with t h e i r analys is and discussion 
are presented i n t h i s t h e s i s . 
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I I . SXPEBIMEIOAL 
A. Matgrlalg 
1. Reagents used for ammonium sulphate f rac t iona t ion of t i ssue 
homog^ate: Ammonium sulphate was obtained from Sarabhai 
chemicals, Baroda. Sephadex G-25 was purchased from 
Pharmacia Fine Chemicals Uppsala, Sweden. 
2 . Reagents used for enzyme assay: Reagents used for the 
as^timatl^«h vf t.-^n^^aKlnat-a d*~>iivit;. wera DL a s p a r t l -
acid (B.D.H., England), ^ - k e t o g l u t a r i c acid (Fluka, 
Swi tzer land) , alanine (S isco , Labora tor ies , Bombay), 
sodium pyruvate (Loba Chemie Indoaustranol Co., Bombay)» 
2,if-dinitrophBnyl hydrazine (Loba Chemie Indoaustranol 
Co., Bombay). 
Disodium phosphate (B.D.H., England), U-amino an t i py r i a 
(B.D.H., England), potassium ferr icyanide (Loba Chemie Indo-
austranol Co, , Bombay) and Phenol (BJ) .H. , Ind ia ) vere used 
in the est imation of a lka l ine phosphatase a c t i v i t y . Reagents 
used for es t imat ion of acid phosphatase a c t i v i t y were c i t r i c 
acid (Sarabhai Chemicals, Baroda), L(-0 taurtaric acid 
(Sarabhai Chemicals, Baroda). Others were as i n sdkaline 
phosphatase. 
Benzoic acid (Sarabhai Chemicals, Baroda), soluble 
s t a rch (E. Merck, I n d i a ) , potassium iodide (B.D.H. f I n d i a ) , 
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sublime iodine (E. Merck, Germany) and potassium fluoride 
(B.D.H., Ind ia ) were used i n the determination of amylase 
a c t i v i t y . 
3 . fteagents used for es t imat ion of p ro te in : Reagents used for 
es t imat ion of p ro te in were Na-K t a r t a r a t e (Glaxo Laborator ies) , 
copper sulphate (Sarabhai Chemicals, Baroda), sodium tungstate 
(B.D.H., I n d i a ) , sodium molybdate (Veb Gen Pharm, Germany), 
Lithium sulphate (B.D.H., I n d i a ) , orthophosphoric acid (B.D.H., 
I n d i a ) , l iqu id t r c E i J ^ . 
i+. Others reagents used: Other reagents used were disodium 
hydrogen phosphate (Sarabhai Chemicals, Baroda). Potassiy.m 
dihydrogen phosphate (Merck, I n d i a ) , sodium hydroxide (B.D.H. , 
l o d i a ) , sodium carbonate (Glaxo. Labora tor ies) , sodium b ica r -
bonate (B.D.H., I n d i a ) , hydrochloric acid (Sarabhai Chemicals, 
Baroda). 
Al l g lass doubts d i s t i l l e d water was used throughout. 
B. M^l^by^s 
1. PH meaaiiyement: pH of solut ion was measured e i t h e r on an 
E l i co Lt-10 pH meter using El ico g lass and calomel e lect rodes 
or with EC combination e lec t rode . The pH meter was ca l ibra ted 
49 
with 0,05 M potassium hydrogen phthalate buffer , pH V.O, a t 
25°C in an ac id ic pH range and with 0,01M sodium te t rabora te 
buffer , pH 9 . 2 , a t 25^0 in the bas ic pH range. 
2 . Optical measurement; Absorbance of so lu t ions i n the 
v i s ib le range was determined on photochem colorimeter , 
model G-110, 
3 . Determination of p ro te in concentration; Pro te in concentra-
t ion »i as measured by the methoci of Towry e t a l . (97) using 
bovine serum albumin as standard. 
Folin-phenol reagent was prepared according t o the 
method of Fol in and Ciocalteu (98) . The copper reagent was 
prepared by mixing h^ sodoium carbctoate, 2^ sodium-potassium 
t a r t a r a t e and ^ copper sulphate in the r a t i o of 100; I : 1 
i n ttie sequence t o avoid p r e c i p i t a t i o n . 
To 1 ml of p ro te in so lu t ion , 5 ml of copper reagent was 
added. After 10 minutes 1 ml of Folin-phenol reagent was 
added and the solut ion was kept for 3^ minutes for the 
development of the colour. Colour i n t ens i ty was read a t 650 
or 700 nm against a blank i n which instead of p ro t e in so lu t ion , 
1 ml water or buffer was taken. 
The p r o t e i n concentration of the solut ion was then 
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determined frcm the ca i i b r a t i on curve obtained with bovine 
serum albumin. 
^ . Assay of ^r^na^ipinases: The a c t i v i t y of transaminase was 
measured by the method of Reitman and Frankel (99)« 
a) P r i n c i p l e t - The pyruvate produced by transamination by 
ALT reac ts with 2,if d ini t rqphenyl hydrazine (DNPH) to give 
a brown coloured hydrazone, which i s measured in colorimeter 
a- /'O ma. The os:alo?'^tate fomied In th« react ion with AST 
decarboxylates spontaneously to pyruvate which i s again 
measured by hydrazone formation. 
b) Reagents: i ) 0,01 M phosphate buffer pH 7«^» i i ) AST^  
subst ra te (200 nM-DL-aspartic acid; 2 DDM alpha ke toglu tara te i -
For the prepara t ion of AST subs t ra te 13.3 g of DL aspar t ic acid 
was dissolved i n minimum amount of 1 N sodium hydroxide aixl the 
pH was adjusted t o 7,U- by addi t ion of sodium hydroxide. Now 
0.Iif6 of alpha Ketoglutar ic acid was dissolved i n i t and the 
pH was again adjusted to 7,U- with 1 N sodium hydroxide. 
Final ly the volume was made upto 5^0 ml with phosphate buffer . 
I t was stored frozen at -15 C. 
i i i ) ALT substra te (200 niM alanine; 2 n*l alpha ke toglu ta ra te ) -
For the prepara t ion of ALT subs t ra te 9 g alanine was dissolved 
in 90 ml water with the addit ion of about 2 ,5 ml of 1 N sodium 
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hydroxide t o adjust the pH to 7,h» Now 0. ll^6 g of alpha keto-
g lu t a r i c acid was dissolved in i t and the pH was adjusted t o 
7.W with 1 N sodium hydroxide. Final ly the volume was made 
upto 500 ml with phosphate buffer . I t was stored frozen at 
-15°C. 
i v ) Stock pyruvate standard:(20 mM) - For the preparat ion of 
stock pyruvate standard 220 mg of sodium pyruvate was 
dissolved in 100 ml of phosphate buffer . I t was stored at 
-15*^0 i n 1 ml a l i quo t s . 
v) Working pyruvate standard (M- mM). 
v i ) 2-14-, d ini t rophenyl i^drazine (1 m) - For the preparat ion 
of 2-lf-DNPH, 19.3 g of 2,If DNPH was dissolved i n 10 ml 
concentrated hydrochloric acid and was made upto 100 mi with 
water. I t was stored in a brown.bottle a t room temperature. 
v i i ) O.if N sodium hydroxide. 
c) Method for est imation of AST: To 0.5 ml of the subs t ra te 
(previously warmed at 37*^ G for 3 minutes) was added 0.1 ml of 
sample, mixed gently and incubated for 60 minutes at 37°C and 
then 0,5 ml of DNPH solut ion was added with gentle mixing. 
After incubation for 20 minutes a t room temperature, 5 ml of 
O.if N sodium hydroxide was added. This was incubated for 
another 10 minutes and the colour i n t e n s i t y was measured a t 
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510 nm. To prepare a con t ro l , sample was added a f te r the 
addi t ion of DNPH. For the preparat ion of blank, water was 
added ins tead of sample. For the prepara t ion of standard, 
0,1 ml of working pyruvate standard was mixed with O.if ml of 
subs t ra te and 0,1 ml of water and the r e s t i s s imi lar to t e s t 
sample, 
(d) Method for es t imat ion of ALT; I t was same as for AST 
determination except for using ALT subst ra te and reducing the 
incubation time t o 3O minutes* 
( e ) Calculat ion; The speci f ic a c t i v i t y of the enzyme was 
ca lcula ted frcmi the following formulas 
Optical densi ty - Optical densi ty 
Speci f ic a c t i v i t y = ^^^ aSSiCii 
Time of incuba- X Pro te in concentration 
t ion ( h r ) , of sample (mg) 
The enzyme ac t i v i t y i n serum can a l so be calculated in 
the following way. 
The pyruvate formed by the sample was responsible for 
the difference between the op t ica l density of t e s t and 
cont ro l (ODj - OD^). 
The pyruvate in 0.1 ml of the working standgird (0,i+ 
umole) produced the difference between the op t i ca l density of 
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standard and blank (ODg - OD^). So the pyruvate formed i n 60 
minutes by AST with 0.1 ml of samples was: 
OD™ - ODf, 
Thus the pyruvate formed per minute per l i t r e of sample by 
AST was : 
= g)- - 0 D ° X 6 7 u » o l e . 
Similarly for ALT, the pyruvate formed per minute per l i t r e 
of sample was: 
OD3- OD3 X O.W X - p X 7 5 ^ = oD^ - ODg ^ ^33 umole 
I n both the cases , the calcula ted pyruvate was converted i n t o 
I . U , / L from the char t given by Wooton (107 ) , 
5. A qflay 9f ^lif^Jt'T rnosphatase: The ac t iv i ty of a lkal ine 
phosphatase was measured by the method of Kind aiKi King (lOOX 
(a) P r i n c i p l e : Phenol released by enzymatic hydrolysis frcm 
phenyl phosphate, under defined conditions of time, temperature 
and pH i s estimated co lo r ime t r i ca l ly . 
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(b) Reagent^; 
i ) Carbonate buffer pH - 9 .9 . 
i i ) Substrate (0,01 mole/L disodium phenyl, phosphate): for 
the prepara t ion of the substrate 2,18 g of disodium 
phenyl phosphate was dissolved i n 1 L of water. The 
so lu t ion was boiled quicklytoto k i l l ar^ y organisms 
followed by raqpid cooling. I t was preserved with a 
l i t t l e chloroform at h^C, 
l i i ) Stock pbenol standara ; : sig/ml) - For tht? i..-i^^.^i^zn 
of stock phenol standard, 1 g pure c r y s t a l l i n e phenol 
was dissolved i n 1 l i t r e 0,1 mol/L hydrochloric acid. 
I t was kept at if*^ C i n a brown b o t t l e , 
i v ) Working phenol standard (1 mg/100 ml) . 
v) Sodium hydroxide (0 ,5 mole/L) 
v i ) Sodium bicarbonate ( 0 , 5 mole/L) 
v i i ) U—amino ant ipyrine - For the prepara t ion of if-amino-
ant ipyr ine so lu t ion , 6 g of i t was dissolved i n a 
l i t r e of water . I t was stored i n a brown b o t t l e at 
room temperature, 
v i i i ) Potassium f e r r i cyanide I For the prepara t ion of. pot a? 
ssium ferr icyanide so lu t ion , 2lf g of i t was dissolved 
i n a l i t r e of water. I t was a lso stored i n a brown 
b o t t l e at room temperature. 
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c) Method; To a mixture of 1 ml buffer and 1 ml substrate 
(^previously warmed a t 37 C for 3 minutes), O.n ml sample was 
added, mixed gently and incubated exactly for 15 minutes at 
37 C and then 0,8 ml of sodium hydroxide (O.5 mol/D was 
added with gentle mixing. 
To i t , 1.2 ml of sodium bicarbonate (0 .5 mol/L) was 
then added followed by addit ion of 1 ml of l+-amino-antipyrine 
solut ion and 1 ml of potassium ferrioyanide solut ion in 
sequence with proper mixing af te r each addi t ion . 
The reddish brown colour was compared immediately at 
510 nm. To prepare the con t ro l , sample was added af te r the 
addi t ion of sodium hydroxide. Blank was prepared by taidng 
1,1 ml buffer with 1 ml of water and the r e s t i s similar to 
t e s t sample. For the prepara t ion of standard l , l mi of 
buffer was mi>:ed with 1 ml phenol standard (1 mg/dl) and the 
r e s t i s s imilar t o t e s t sample. 
(d) Calculations The spec i f ic ac t iv i ty of the enzyme was 
calculated by the formula as in the transaminases. 
The enzyme a c t i v i t y i n serum can a l so be calculated i n 
the following way. 
The amount of phenol present i n the standard tube was 
10 jug. Thus the phenol produced in 15 minutes in the t e s t was 
c: 6 
OD-,-OD 
WrT^QQ ^ l^/^Ej Hence 100 ml of sample would l i b e r a t e 
S B 
OD„-OD^ 
QD -QD X ''^ D[»g of phenol. Since 1 KA i s the production of 
o B 
1 mg of phenol in 15 minutes under the condit ions of the t e s t . 
0D„ - OD 
Alkaline phosphatase 757* n n " X- 10 
a c t i v i t y (KA/dl) ""s " ^ B 
was determined by the method of King and Jegatheesan (IO1). 
( a ) P r i n c i p l e ; - I t i s same as described i n alkal ine phos-
phatase . 
(b) Reagents: All are same as in alkal ine phosphatase except 
the buffer and the t a r t a r a t e . 
i ) C i t r a t e buffer (PH h.9)i For the prepara t ion of c i t r a t e 
buffer , i+2 g of c ry s t a l l i ne c i t r i c acid was dissolved i n 
water. To i t 376 ml of 1 mol/L sodium hydroxide was added 
and made upto 1 l i t r e with water. pH was checked and 
prepared with a few drops of chloroform a t U- C . 
i i ) Tar ta ra te solut ion (1 mol/L): For the prepara t ion of 
t a r t a r a t e so lu t ion , 15 g of t a r t a r i c acid was dissolved i n 
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about 70 ml of water. 18.5 ml of 1^ mol/L sodium hydroxide 
was then added and the pH was adjusted t o M-.9. F ina l ly the 
volume was made up to 1OO ml with water. I t was stored i n a 
dropping b o t t l e a t i+°C. 
c) Method:- For t o t a l acid phosphatase, 1 ml of c i t r a t e buffer 
was mixed with 1 ml of subst ra te in a t e s t tube and placed 
i n an incubator a t 37 C for 3 minutes, TJaen 0,2 ml of sample 
was added, mixed gently and incubated for 1 hour exactly a t 
37 C and tfier^ •* ^ 1 'yf 0.5 wol/^ T sodlupi hvdroxide was added. 
To i t , 1 ml of 0.5 mole/L sodium bicarbonate was added 
followed by addi t ion of 1 ml of M—amino ant ipyr i r^ and 1 ml 
of potassium ferr icyanide solut ion in sequence with, proper 
mixing a f te r each addit ion. 
The reddish brown colour was then contpared immediately 
a t 510 nm* 
For the determination of the p r o s t a t i c f rac t ion 
( t a r t a r a t e l a b i l e ) , a second tube was prepared exact ly in 
the same manner except for adding a drop of t a r t a r a t e solut ion 
(1 mole/L) before p ipe t t ing the serum. To prepare the cont ro l , 
sample was added a f te r the addition of sodium hydroxide. 
Blank was prepared by taking 1.2 ml buffer with 1 ml 
of water and the r e s t i s s imilar to t e s t sample. For the 
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prepara t ion of standard, 1.2 ml of buffer was ndxed with 1 ml 
of phenol standard (1 mg/dl) and the r e s t i s s imi lar to t e s t 
sample. 
d) Calculat ion; The spec i f ic a c t i v i t y of the enzyme was 
Calculated by the formula as in the transaminase. The enzyme 
ac t iv i ty in the serum can a l so be calcula ted i n the following 
way. 
. The anraint j2f "Lcr.cl xrejjent i r- . thc standard tuLe —-
10 ^ g . Thus the phenol i s the t e s t was 
ODm - OD^  
OD: - ODI X 5 mg of phenol. 
o B 
Since 1 KA u n i t i s the production of 1 mg of phenol in 60 
minutes under the condit ions of the t e s t . 
0D« - 0D„ 
Acid phosphatase 7^ ?^  = * - X 5 
a c t i v i t y (KA/dl) = "^S " "^B 
To obtain the t a r t a r a t e l a b i l e phosphate, the above formula 
was used to ca lcu la te the r e s u l t s of the two t e s t s (one 
without and the other with added t a r t a r a t e so lu t i on ) . The 
difference between the r e s u l t s represented the phosphatase 
which had been inac t iva ted by t a r t a r a t e . 
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7 . Assay of amylase:-' The ac t i v i t y of amylase was measured 
by the lodometrlc method of Caraway and Wendell (102). 
(a) Pr inc ip le J Starch forms a blue co l lo ida l ccoiplex with 
iodine in so lu t ion and the in t ens i ty of the colour i s d i r ec t ly 
propor t ional t o the concentration of the s t a rch . The blue 
colour produced by the s ta rch subs t ra te when combined with 
iod ine , i s measured af te r incubation with saiople and compared 
t o a con t ro l . The decrease in colour i s proportionaJ to the 
amylase a c t i v i t y . 
(b) Reagents;- i ) Buffered s ta rch substrate (pH 7 ) : - For 
the prepara t ion of buffered s t a rch subst ra te I3 .3 g of dry 
anhydrous disodium hydrogen phosphate and U-.3 g benzoic acid 
were dissolved i n 25O ml water. I t was brought to b o i l i n g . 
A separate so lu t ion was made with 0.200 g of soluble s t a rch 
i n 5 ml of cold water i n a beaker and was added^to the 
bo i l ing mixture, r ins ing the beaker out with addi t ional 
cold water. Boil ing was continued for 1 minutes followed by 
cooling to room temperature gnd di lu ted to 50O ml with water 
f i n a l l y . I t was stored at -^ C. 
i i ) Stock Iodine Solution (0.1 M):- To prepare stock iodine 
so lu t ion , 13.5 g of pure sublimed iodine was dissolved in a 
so lu t ion of Zh g of potassium iodide in about 100 ml water 
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and the f i n a l volume was made upto 1 l i t r e with water, 
i i i ) Working Iodine solut ion (0.01 N) : - For i t ' s preparat ion 
50 g of potassium fluoride was dissolved in a l i t t l e water. 
To i t , 1OO ml of stock iodine solut ion was added and the 
f i na l volume was made upto 1 l i t r e with water. I t was stored 
in a brown b o t t l e a t M- C. 
c) Method;.. The sang)le was d i lu ted 1 in 10 with 0.9^ s a l i n e . 
XC i m l^ of i>ur fe i^u r-^aivh bUbevrai^e {iu"* viyUsIy v.ai-2jsu j . : 
37°C for 3 minutes) , 0,1 ml of the d i lu ted sample was added, 
mixed gently and incubated for exactly 15 minutes at 37*^C. 
Now O.if ml of working iodine solut ion was added, mixed well 
followed by addi t ion of 8,5 ml of water with proper mixing. 
For the control 1 ml of buffered subs t ra te , 8,6 ml of water 
and O.if ml of iodine were mixed in sequence. 
The colours were compared immediately at 660 nm using 
water as a blank, 
d) Ca lcu la t ion^ :" The spec i f ic ac t iv i ty of the enzyme was 
calculated by the formula as in the t ra isaminases . 
The a c t i v i t y of the enzyme in serum can a lso be calcu-
la ted in the following way. The control tube contained O.lf mg 
s t a r ch . The amount of s t a rch which had been digested was 
the re fo re : 
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0D„ - 0D-, 
The amylase un i t i s the amcxint of enzyme digest ing 
5 mg of s t a rch in these condi t ions . !Hie amount of enzyme 
present i n 0,01 ml of the sen i le was; 
ODp - 0D_ 
•^—:7^ X OA/5 u n i t s , thus 
C B 
Amylase a c t i v i t y _ C " T ^ Q . /^ ion/o Di 
( u n i t s / d l ) - CD^ - ODg ^ °-^^5 X 100/0,01 
—W A X 800 
" OD^  - OD3 ^ « ^ 
8 . Ext rac t ion of p ro te in from various t i s sues for enzvme assavr 
Pro te in was extracted fran l i v e r , kidney, ske le ta l 
muscle, hear t muscle, brain and lung t i s s u e s of buffalo, goat 
and r abb i t . 
Each t i s sue (20 g) was f i r s t washed with ice cold water 
and then per iphera l membrane and connective t i s sues were 
removed followed by cut t ing i n to small p i eces . I t was then 
homogenized in phosphate buffered sa l ine i n a homogenizer for 
10-15 minutes. The homogenate was ceutrifuged at 7,000 rpm for 
1 hour t o remove the d e b r i s . 
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The supernatant was col lected and was saturated with 
3>(^ ammonium sulphate. 
After incubation for 2 hours, t h i s was centrifuged at 
6000 rpm for 30 minutes ani cleaT supernatant was col lec ted . 
To remove ammonium sulphate , the supernatant was passed 
on Sephgdex G-25 column. Sephadex G-25 column (20 x 1 cm) 
was pacloed and equi l ib ra ted with phosphate buffered s a l i n e . 
Void volume of the column was determined by passing 1 ml of 
(5 mg/ml) blue dexlraxi. The void vulume was found bo be 3^ ml. 
The column was operated a t a flow ra t e of WO ml/hour. The 
supernatant obtained from ammonium sulphate p r e c i p i t a t i o n was 
passed on t h i s Sephadex 0-2^ column a-id p ro te in e lu t ing i n 
the void volume was collected and used to determine enzyme 
a c t i v i t y . 
Before reusing, the column was washed extensively 
with phosphate buffered sa l ine t o remove ammonium sulphate . 
Human serum and serum from buffalo , goat and rabbi t 
were used as such for enzyme ac t iv i ty es t imat ion. 
C. S t a t i s t i c a l Evaluation 
( a ) As the study group i s l a rge , observations in t h i s study 
were s t a t i s t i c a l l y evaluated by using »Z» t e s t . The mean and 
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standard devia t ions were calculated with the help of an e l e c -
t ron i c ca l cu la to r which provided the above two da ta d i r ec t ly 
Z - ^1 ' \ 
\ / a, * ti^. 
Where n . , X^  and S^ are respect ively the number of i tems, mean 
and standard devia t ion of the values of f i r s t s e r i e s , n^« X^ 
wLtj. S2 &re rej>p6ctivel^ tlas uiuuber of Iteiua, monXk and staxidaru 
dev ia t ion of the values of second s e r i e s . 
'p« value was calculated from the probabi l i ty tab les 
by comparing the value of 'Z*. 
(b) S t a t i s t i c a l evaluat ion of the observations was a lso done 
using s t u d e n t ' s »t» t e s t . 
t = L22. s/n—z 
"2 
The value of S was calculated before hand by the formula; 
n^ ••- r ^ - 2 
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Where n^, X^  and S•^ are the number of Items,mean and standard 
devia t ion of the values of f i r s t s e r i e s respec t ive ly , ng, Xg 
and S2 are the number of i tems, mean and standard deviat ion 
of the values of second se r i e s r e spec t ive ly . 
The value of ' V thus obtained wais compared with the 
probabi l i ty t ab les given by Fischer and Yates and values of 
•p ' noted, p value l e s s than 0,05 i s s ign i f i can t . 
HI 
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I I I . HESUIJIS AH) DISCUSSION 
The l eve l of AST, ALT, AIP, AGP and amylase in different 
mammalian t i s sues were determined in appropriate buffer 
systems. Tissue homogenate was f i r s t centrifuged and super-
natant was salt-fractionated at 3 ^ aimnonium sulphate satura-
t ion . The act iv i ty was measured in the supernatant after 
removal of tiie sa l t lay gel chrc^atograp]:^ on Sephadex G-25 
column. The specif ic activity was determined in seven 
different t i s sues of buffalo, goat and rabbit; the l e v e l of 
enzymes was also determined in human serum. Table 10 
(Figs . 1-3) shows the spec i f ic act iv i ty of AST in the various 
t i s sues of different mammalian species . Strikingly the serum 
l e v e l of AST was found 0,031 j . 0,001 OD/mg/hr regardless of 
a l l the four species l i s t e d i n Table 10, Similar observations 
were made on AST a c t i v i t i e s of skeletal muscle, lung, brain, 
l i v e r and probably heart. In the l a t t e r , the variation i n 
AST a c t i v i t i e s in different species was about 12^ which i s 
not markedly different from the experimental error of 8-19^ 
with which the act ivi ty of enzymes could be measured in these 
s tudies . The act ivity in kidney tissue was nearly the same 
in goat and buffalo but s ignif icantly low in rabbit. The 
discrepancy cannot be ascribed to experimental error, i t ' s 
significance remained unclear to us . The activity of AST was 
found to be highest in brain and low in lung and l iver . The 
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a c t i v i t i e s in heart and ske l e t a l muscle were s ign i f ican t ly lower 
than tha t fownd i n b ra in t i s sue but were subs tan t ia l ly higher 
than the values found in lung and l i v e r . These findings 
regarding t i s sue d i s t r i b u t i o n cor re la te well with the findings 
(Table 6) of other c l i n i c a l enzymologists on human t i s sues 
except t h a t , in present s tudy, the a c t i v i t y in l i v e r wa^ much 
lower than t h a t reported by others (96,103,10^-). As the method 
of preparaticxi of enzyme san^le wais d i f fe ren t i n a l l the 
reported s tud ies such canparisen a t bes t can only be 
considered . i u t i l e . 
The t i s sue d i s t r i b u t i o n of AH a c t i v i t i e s i n buf fa lo , 
goat and r abb i t i s summarised i n Table 11 (Figs« W-6). I t 
can be seen tha t the species dependent differences for various 
t i s s u e s range from h-^(^. Maximum difference was noted i n 
lung followed by l i v e r . The enzyme l e v e l s for buffa lo , goat 
and r abb i t kidney were i n v a r i a n t . The difference i n enzyias 
l eve l s of s k e l e t a l muscle among the three species was small 
and hardly s ign i f ican t considering the e r r o r of 15ji with 
which the a c t i v i t y could be measured i n d i f fe ren t independent 
experiments. 
The serum leve l of ALT was s ign i f i can t ly higher i n 
rabb i t than tlipse of buffalo and goat serum i n which cases 
the values were s imi la r but not i d e n t i c a l t o that found i n 
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human within the permissible experimental error . For the same 
species, the level of ALT was found to be markedly higher In 
skeletal muscle, heart and brain and the values were substan-
t i a l l y lower in l ive r , lung and serum. The ALI level of 
kidney tissue vaa in between. Similar pattern was noted for 
ALT ac t iv i t i e s in different t issues of buffalo, goat and 
rabbit . Despite experimental uncertainty these resul ts do 
suggest that AIT level i s higher in skeletal muscle, heart 
and brain. 
Table 12 (Figs. 7-9) shows the level of AIP in different 
t issues of different mammalian species. In heart and the serum 
the enzyme concentrations were nearly the same in buffalo, 
goat and rabbit . Maximum species variation was found in kidney 
tissue where the average deviation was 5 ^ * In l ive r , lung, 
skele ta l muscle and brain, the differences among the three 
species were in the range of 25-29^• Except serum the level 
of enzyme in other t issues was found to be highest in goat 
followed by buffalo and rabbit . Tissuewise highest level was 
measured in kidney followed by lung. The levels in heart , 
brain and skeletal muscle were substantially Icwer. I t seems 
that the level of AIP in serum i s same regardless of species. 
Similar conclusions are valid for activity in heart muscle. 
However, in other t issues the differences in the level of 
enzyme among three species eire small but significant; the lone 
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exception appears to be kidney where the va r ia t ion among the 
three species I s substant ia l* 
Tissue d i s t r i b u t i o n of ACP I s summarised In Table I3 
and I s grsphlcal ly shown In Figs , 10-12, Analysis of the 
r e s u l t s shows t h a t the l eve l s of ACP In hear t and ske le ta l 
muscle were the same for a l l the species namely buffa lo , goat 
and r abb i t . In other t i s sues the va r i a t i on among the three 
species were between 22-38p(. Maximum devia t ion was noted in 
case of k ldne j , Tiifc serum leve l of enzyme wais four*;- to W 
Invariably low In human, r a b b i t , goat and buffalo in comparison 
t o other body t i s s u e s . The l eve l of AGP was s ignif icant ly 
higher in bra in t issue of a l l the three species followed by 
kidney and lung. 
The l e v e l s of amylase i n d i f f e r en t t i s sues c^ buffalo, 
goat and rabb i t are summarised i n Table 1^ and t issue d i s t r i -
but ion for enzyme of each species i s depicted i n F igs , 13-15* 
The serum leve l s of amylase i n human, r abb i t , goat ajod 
buffalo were found t o be same within experimental e r ro r . The 
amylase a c t i v i t y of lung, b r a i n , hea r t and serum were almost 
s imi l a r . The enzyme l e v e l s i n l i v e r and kidney were substan-
t i a l l y higher regardless of the spec ies . The highest leve l 
was found in the l i v e r followed by kidney. The lowest level 
was found in the ske le t a l muscle. 
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TABLE 16: COMPARISON OF NORMAL SERUM K Z^YME PROFILES OF AUG ARE 
POPULATION WITH UTERATURE VALDE ( 1 2 ) . 
S.No. Enzyme A c U v i t y (Mean j - 2 S.D.) 
This s tudy L i t e r a t u r e valae(12) 
1. AST ( I . U . / L ) 
2 . AU: (I-U/'L) 
3 
13.8 J- 9.2 
9.3 J 5.9 
8,6 ^ 5 . 0 
h. Acid phosphatase (KA/dl) 1.5 J - 1 . 1 
5. Amylase (S.U/dl) 180.8 ^ 32.5 
Alkaline phosphataise 
(KA/dl) 
10.0 J. 5.0 
8.0 ^ 5.0 
2 .2 .^ 1.3 
130.0 ± 70.0 
93 
After inves t iga t ing the d i s t r i b u t i o n of AST, ALT, ALP, 
ACP and amylase i n various t i s s u e s of three mammalian systems, 
we set out to inves t iga te the normal l eve l of these c l i n i c a l l y 
important enzymes in two hundred blood sanqples received fran 
c l i n i c a l l y healthy persons of Aligarh. The r e s u l t of the 
l e v e l s of a l l the five enzymes are tabulated i n Appendix I , 
S t a t i s t i c a l analys is of the r e s u l t s was done as described in 
the experimental sec t ion . The r e s u l t s of t h i s analysis are 
l i s t e d i n Tables 15-^3. 
The Table 15 shows the age and sex d i s t r i b u t i o n of 
the study group. The d i s t r i b u t i o n i s a l so shown graphically 
i n F ig . 16. The maximum number of cases ( 2 1 . ^ ) were in the 
age group of 2O-3O yea r s . However, lowest number ( 6 . ^ ) were 
in the age group of O-1O yea r s . 
I n t h i s study there were more male cases i6h,%) as 
ccmrpared t o female cases (35*'^)* 
I t can be seen from Table 16 t h a t the normal values 
of serum enzymes found in t h i s study are in good agreement 
witii those reported in l i t e r a t u r e (105«>107), However, the 
normal amylase l eve l found i n t h i s study on Aligarh population 
i s s ign i f i can t ly on higher rcaige. 
Analysis of the serum enzyme l eve l was also done 
according to sex. The serum enzyme p r o f i l e s i n d i f fe ren t sex 
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groups are l i s ted in Table 1? (Figs. 17,18). S ta t i s t i ca l ly 
significant differences were obtained in AST (p<0.0^) and 
acid phosphatase values (p< 0.01) between males and females 
with higher values in male. The sex dependent differences in 
the ac t iv i t i e s of the res t of the enzymes seem to be s t a t i s -
t ica l ly insignificant (p> 0.0^). Generally males tend to 
exhibit somewhat higher levels of alkaline phosphatase than 
do women. This may be related to differences in skeletal 
mass, but i t i s also related to greater physical activity of 
the mala which serves as a stimulus for an Increase in bone 
formation (108,109). Healthy males also show sl ightly higher 
transaminase levels than females (33). 
Table 18 (Figs. 19,20) depicts the serum enzyme pro-
f i l e s in children (0-12 years) and adult (12-70 years) age 
groups. S ta t i s t ica l ly significant higher values of acid phos-
phatase (p< , O.OOi) were found in children-age-groups in compa-
rison to the adults. For other enzymes, the difference between 
children and adult age groups i s not s t a t i s t i c a l l y significant 
(p)> 0,05). The level of both acid and alkaline phosphatases 
i s higher in growing children than in adult. This i s due to 
the increased bone growth at th i s age (109,110-112), Trans-
aminase level i s also higher in children-age-group (111). 
Table 19 shows the serum AST level in different age and 
sex groups. S ta t i s t ica l ly significant differences in the 
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eazyme level between males and females were found In the age 
groups of second and sixth decades (p< 0,05), in both the 
age groups males were found to have higher values* 
Table 20 depicts the serum ALT level in different age 
and sex groups. No stat ist ical ly significant differences 
were found between male and female of different age groups. 
Serum alkaline phosphatase level in different age and 
sex groups.is ^OBBiiarised in Table 21. Statistically significant 
higher values ( p < 0.05) were found in the males of second 
decade age group. 
Table 22 shows the serum acid pho^htase level in 
different ageLand sex groups. .Statist ically significant 
differences between male and female were found in the age group 
of second and fifth decades ( p < O.05). In both age groups 
males were found to have higher values. 
Serum amylase level in different age and sex groups 
is.depicted In Table 23. No statist ically significant 
differences were found between males and females oi different 
age groups. 
Iiq)ortant conclusions based on the results discussed 
above are summarised belcwt 
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1. Tb8 serum levels of AST, ALT, Alf, ACP and amylase are 
almost similar in a l l the four mammalian species. 
2 . Tissue concentration of these enzymes are much higher 
than their respective serum levels except in case of 
amylase. 
3. Since in this study consistently similar pattern of 
tissue distribution of the various enzymes were found 
in three different mammalian species, namely, buffalo, 
; goat End-rabbit, the rerults can safely be extrapo^a*^'' 
to human being. 
M-. Species dependent differences in the values of any enzyme 
in a specific tissue varies from h^5^ approximately. 
5. lloB activity of AST i s highest in brain followed by heart 
and skeletal muscle irrespective of species. The enzyme 
concentration i s lov in lung. 
6. For the same species, ALT level i s higher in skeletal 
muscle, heart and brain and low in l iver , lung and serum. 
7. ALP concentration i s maximum in kidney followed by lung 
regardless of the species. The levels in heart,brain and 
skeletal muscle are substantially low. 
8. The level of ACP i s significantly higher in brain tissue 
followed by ld.dney and lung regardless of species. 
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9. The level of amylase i s highest in l iver and lowest in 
skeletal nuscle. 
10. AnQrlase activit ies of lung, brain, heart and serum of 
any of the species are similar. 
11. The normal serum axoylase level i s significantly on the 
higher range in Aligarh population. 
12. AST and ACP levels in serum are higher in males than in 
females. 
13* The level of ACP in serum i s remarkably higher in children 
than in adult. 
1U-. Serum AST level i s higher in males of second and sixth 
decades than in females of corresponding age group. 
15* The levels of ALT and ainylase in seium are not dependent 
on age or sex. 
16. The level cf Alf in serum i s higher in males of second 
decade than that of the females of corresponding age 
group. 
17. ACP level in the serum i s higher in males of second and 
f i f th decades than that of tbe females of corresponding 
age group. 
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IV. SMMS. 
Tissue enzymes are released l a tbe plasma after ce l l 
damage or ce l l deat^ In a specific organ or t i ssue. So the 
elevated level of serum enzymes which are specific for a 
par t i cu la r t issue wil l undoubtedly have a great diagnostic 
value. The s ta tes of health and disease of a specific t issue 
i s also reflected by ax^ changes of the enzymes in the tissue 
i t s e l f . But i t i s rarely possible to estimate the enzymes in 
human t i ssues . However as various metabolic patterns of 
mammalian species do not differ much fron that of human t issues 
at leas t quali tat ively the data on enzyme levels gathered on 
t issues of other mammals can be compared to that of human. 
Furtherffl(»re i t i s an established scient i f ic fact that when 
consistent resul ts of an experiment are observed in three 
different mammalian species, the resu l t s can safely be extra-
polated to human beings. Tbeirefore we have studied the tissue 
dis t r ibut ion of AST, AlIE, Ali^, ACP and amylase in buffalo, goat 
axid rabbi t . Since the normal levels of serum enzymes are 
influenced much by the nutr i t ional s ta tus , age, sex and 
ethnic groups (20a), their detennination i s essent ia l in a 
country l i t e ours where these values vary substantially frcm 
one population group to another. Accordingly we have deter-
mined the serum level of the above mentioned enzymes in human. 
I l l 
These enzymes were measured In two hundred blood saoqples 
collected frooa cl inically healtl^ Individuals of Allgarh 
population of different age and sex. 
The outcome of th i s endeavour i s described below. 
Interestingly there was almost no species dependent 
differences in the level of AST in serum, skeletal muscle, 
lung, brain, l iver and heart though t issue dependent variations 
were found. The activity in kidney tissue was nearly the same 
in goat and buffaic but significantly low in rabbit . The 
discrepancy can not be attributed to experimental error only. 
I t ' s significance i s not clear to us . The level of AST was 
found to be highest in brain and low in lung and l iver . The 
ac t iv i t ies in heart and skeletal Busde were in between. These 
findings regarding tissue dis t r ibut ion are in good agreement 
with the findings (Table 6} of other c l in ica l enzymologists 
on human t issues except tha t , the activity found in l iver in 
the present study was much lower than that reported by 
others (96,103,1 Of), AS the method of preparation of enzyme 
sample was different in a l l the reported studies such comparison 
i s hardly applicable here. 
Species dependent differences in the levelofALT for 
ft 
various t issues range from if*5^* Maximum difference wsis noted 
in lung followed by l iver . The enzyme levels were invariant 
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In the kldaey tissue irrespective of species. The serum level 
of ALT was almost similar In buffalo, goat and human but signi-
ficantly higher In rabbit. For the same species, the level of 
ALT was found to be markedly higher in skeletal muscle, heart 
and brain and substantially lower in l ive r , lung and serum. 
Despite experimental Inaccuracy these resul ts suggest that 
ALT level i s higher in skeletal muscle, heart and brain. 
In heart and serum the ALP levels werte almost same 
regardless of species. Species dependent variation was mazl-
mum ( 5 ^ ) in kidney tissue followed by l i ve r , lung, skeletal 
muscle and brain (25.29^). Except serum the level of enzynia 
in other t issues was found to be highest in goat followed by 
buffalo and rabbit . Among the t issues studied here, maximum 
level was found in kidney. The concentrations in heart , 
brain and skeletal muscle were significantly low. 
The levels of ACP were the same in heart and skeletal 
muscle for a l l the three species. Species dependent variation 
was noted maximum in kidney and intermediate for the other 
t issues (22-38$(}. The serum level of the enzyme was found to 
be very low in a l l the four species in comparison to other body 
t i s sues . Tissuewise highest concentration of the enzyme was 
noted in brain regardless of species followed by kidney and lung. 
\u 
The serum amylase levels were found to be similar l a 
a l l the four manmalian systems. Tb& enzyme levels were subs-
tant ia l ly higher in l iver and kidney irrespective of species. 
TtaB lowest activity was measured in the skeletal muscle. 
The anylase ac t iv i t ies of lung, brain, heart and serum 
were almost similar. 
After studying the tissue dis t r ibut ion of these enzymes 
iti^  dif^fereat mannallaji systems, we measured tbe normal serum^ 
levels of these enzymes in two hundred cl inical ly healthy 
individuals of Aligarh population. 
S t a t i s t i c a l analysis of the resul ts shews that the 
normal serum levels found in this study correlate well with 
those reported in l i t e ra ture (IO5-1O7) except in case of anylase 
which was found to be significantly on higher normal range in 
Aligaz^ population. 
S ta t i s t i ca l ly significant sex dependent differences in 
the enzyme levels were found in case of AST (p<0.05) and AGP 
(p<0.05) with higher values in male. 
The sex dependent differences in the ac t iv i t i e s of the 
res t of the enzymes seem to be s t a t i s t i ca l ly insignificant 
(p>0 .05 ) . Generally males tend to show somewhat higher level 
of alkaline phosphatase than women do. This may be related 
to differences in skeletal mass, but i t i s sGLso related to 
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greater physical activity of the male which serves as a stimulus 
for an Increase in bone formation (108,109). Healthy males 
also exhibit sl ightly higher transaminase levels than females (33). 
S t a t i s t i ca l ly significant higher values of AGP (p< 0,001) 
were found in children (0-12 years) in comparison to adult 
(12-7O years)^ Age dependent variations in enzyme levels was 
insignif icant for other enzymes (p> 0,0^). The level of 
both acid and alkaline phosphatases i s higher in growing 
children than in adult. This i s due to the increased bone 
growth at th i s age (IO9, 110-112). Transaminase level i s 
also higher in children age group (111). 
Males in second and sixth decades were found to have 
s t a t i s t i c a l l y significant higher values (p < 0,05) of seium 
AST than tha t of the females of the same age groups. 
S ta t i s t i ca l ly significant higher values of serum AIP 
(p < 0.05) were found in the males of second decade age 
group. 
No s t a t i s t i c a l l y significant differences (p>0,05) were foui 
in serum AIT£'amylase levels between males and females of different 
age groups. 
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Sta t i s t i ca l ly significant higher values of serum AGP 
was foual i a males of second and f i f th decade age groups than 
that of the females of corresponding age groups. 
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APPENDIX - I SERUM ENZYME PiiOFILES OF THE STUDY GfiOOP OF AIIGARH 
POPUUTION. 
S.No. Name Age Sex 
y r s . 
AST 
I U / L 
ALT 
IU/L 
AIP 
KA/dl 
AGP 
KA/dl 
Amylase 
SU/dl 
1 . 
2 . 
3. 
h. 
5. 
6 . 
l\ 
9 . 
1 0 . 
1 1 
12 . 
1 3 . 
Ilf. 
15. 
1 6 . 
17 . 
18 , 
1 9 . 
2 0 , 
2 1 . 
2 2 . 
2 3 . 
2lf. 
25. 
2 6 . 
11: 
2 9 . 
3 0 . 
3 1 . 
3 2 . 
33. 
3»f. 
35. 
36. 
11: 
39. 
IfO. 
K. 
L.S, 
R. 
M.H. 
Z.V.N. 
A.E. 
S. 
S. 
s. H.C .M* 
'-'.D. 
S.A. 
J . P . 
N. 
M.S. 
S. 
A 
S.E. 
A. 
B.K. 
N* 
A. 
R. 
N. 
N 
I . F . 
M.S.T. 
U. 
s. A.M. 
K. K.iT . 
K. 
M. 
R.T. 
S.A. 
A.S . 
A.N. 
A.K. 
B. 
M. I . 
50 
20 
llf 
^5 
U2 
u 
25 
J+0 
60 
u.«> 
U-0 
IfO 
60 
ifO 
28 
10 
62 
k 
1+8 
55 
29 
^.0 
53 
^5 
17 
80 
20 
20 
60 
65 
M-O 
llf 
27 
25 
5 
15 
21 
50 
22 
F 
F 
M 
M 
M 
M 
F 
F 
M 
M 
F 
M 
M 
M 
F 
F 
M 
F 
M 
M 
M 
F 
M 
M 
F 
F 
M 
F 
F 
M 
M 
M 
F 
M 
M 
M 
M 
M 
M 
M 
13 
15 
13 
20 
19 
7 
9 
17 
17 
17 
2(3 
17 
19 
15 
13 
15 
17 
13 
13 
15 
13 
15 
7 
11 
9 
7 
17 
9 
6 
17 
13 
13 
13 
17 
19 
6 
7 
7 
9 
19 
I 
16 
12 
7 
9 
I 
6 
6 
10 
9 
l l f 
10 
5 
1? 
7 
10 
10 
12 
10 
U+ 
6 
15 
12 
7 
7 
13 
7 
7 
10 
10 
7 
5 
6 
7 
7 
9 
1if 
5.0 
6.5 
7.5 
8.0 
5.0 
10.0 
6.0 
9.0 
h,0 
if.O 
11 .0 
5.0 
6 . 0 
12 .0 
11 .5 
6.0 
7.0 
7.5 
9.0 
If.O 
8.0 
6 . 0 
7 . 0 
5.0 
8.0 
5.0 
5.5 
5.0 
9.5 9.0 
6.5 10.0 
5.0 
10 .0 
1.2 
1.2 
1.0 
2 . 0 
2.7 
1.0 
1.2 
1 . ^ 
1.2 
1.0 
2 . 0 
l . l f 
1.8 
1.3 
1.U-
3 . 0 
1.2 
2 . 0 
1.5 
1.0 
1.lf 
1.5 
2 . 0 
1.0 
1.5 
2 . 0 
1.0 
1.6 
2 , 0 
1.7 
1.0 
2 . 0 
1.2 
1.7 
2 . 2 
1.6 
1.3 
1.2 
1.3 
210 
180 
182 
210 
150 
188 
188 
191 
1Q6 
1 on 
179 
189 180 
188 
176 
17«J 
200 
181 
176 
18^ 
150 
215 
170 
190 
IMf 
l l fO 
161+ 
159 
160 
180 
20+ 
190 
I83 
17^ 
202 
188 
190 
183 
166 
APPENDIX I ( Con td , ) 
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S.No. Name Age Sex AST 
lU/L 
ALT 
lU/ l . 
ALP 
KA/dl 
ACP 
KA/dl 
Amylase 
SU/dl 
h^. 
If 2 . 
i f3-
Mf. 
V5. 
i f6. 
W7. 
If 8 . 
If 9 . 
50. 
51. 
52. ??• 
5^. 
55. 
56. 
?^-58. 
59. 
6 0 . 
6 1 , 
6 2 , 
^3-
6if, 
65* 
66. 
^ ^ 68, 
69. 
70. 
71. 
72. 
73. 
7^. 
7?-76. 
7?* 
78. 79. 
&0. 
8 1 . 
8 2 . 
§3-8if 
A . 3 . 
H . K . P . 
J . P . 
P.M. 
M. 
M 
G. 
M . I . 
M.K. 
A. 
S .A .H. 
M. 
M . S . 
J . S . 
B . 3 . 
H. 
B.K. 
S.M. 
E . A . 
B . 
N . I . 
A.K. 
S . 
N.B. 
Y.K. 
A. 
G. 
P . 
S . 
Q 
T . 
K . S . 
V . S . 
N.M. 
S .A. 
L .A. 
H . B . 
5 . P . 
A.D. 
S . 
P . 
s.w. I . D . 
C. 
15 
50 
75 
2 0 
18 
18 
U-0 
65 
ifO 
18 
25 
1 0 
37 
30 
53 
hO 
30 
32 
2 0 
21 
8 
22 
21 
^0 
10 
35 
16 
15 
3 0 
3 0 
19 
35 
^5 
50 
21f 
17 
^P H 
35 
30 
16 
50 
2lf 
7 0 
F 
M 
M 
M 
M 
F 
M 
M 
M 
M 
M 
F 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
F 
F 
M 
F 
F 
F 
F 
M 
M 
M 
M 
M 
F 
M 
F 
F 
F 
M 
F 
F 
M 
M 
6 
6 
17 
11 
2 0 
11 
17 
19 
15 
13 
13 
17 
9 
17 
15 
19 
11 
9 
9 
19 
19 
9 
19 
11 
13 
19 
11 
9 
19 
7 
17 
17 
15 
13 
7 
17 
15 
10 
5 
15 
7 
5 
9 
17 
7 
12 
7 
1C 
12 
6 
10 
6 
6 
IM-
12 
9 
12 
15 
1U 
12 
^? 6 
7 
7 
12 
16 
h 
7 
7 
15 
1 ^ 
6 
7 
12 
6 
12 
9 
9 
l i f . 
11+ 
7 
9 
1 0 . 
9 
10 
12 
6 
6 
^.5 
11 .0 
5 . 0 
7*5 
11 .0 
9 . 0 
5 . 0 
5 . 0 
13 .0 
7 . 0 
5 . 0 
8 . 0 
8 . 0 
< r. 
11 .0 
7 .0 
h,0 
9 . 0 
8.5 
7.5 
7 . 0 
7 .0 
5 . 0 
13.0 
6 . 5 
8 . 0 
5-5 
5.5 
10.5 
13 .0 
7 .0 
9 . 0 
7 .0 
8 . 5 
8 . 5 
7 . 0 
5 . 0 
6 . 0 
10.0 
6 . 0 
7 . 0 
10.0 
11.0 
8 . 5 
1.2 
2 . 2 
l f .2 
2 . 0 
3 .0 
1.3 
1.2 
1.0 
2 . 0 
1.2 
1 . 0 
1.8 
•'2 
1 ^ . 
1.M-
1 .3 
1 .0 
1.2 
1 .5 
1 .0 
2 . 0 
1.2 
1.2 
•1 w 
• • • 
2 . 0 
1 .7 
1 .5 
1.2 
1.2 
1 .5 
1 .8 
1.2 
i f . O 
3 . 5 
2 . 0 
1.2 
1.3 
2 . 0 
1.3 
1 .2 
1.2 
1 .0 
1.3 
1 .0 
17U-
195 
205 
196 
19^ 
198 
176 
l i fO 
189 
205 
I6 l f 
• «» Sir 
•• < ~ 
iu-d 
183 
198 
1 9 | 
170 
155 
166 
195 
205 
176 
176 
175 
2 0 2 . 
173 
173 
177 
165 
201+ 
201 
150 
165 
157 
160 
185 
193 
196 
I6 l f 
150 
171 
172 
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S.No, Name Age Sex AST 
IU/L 
ALT 
IU/L 
ALP 
KA/dl 
AGP 
KA/dl 
Amylase 
SU/dl 
85. 
86. 
87. 
88. 
89. 
90 . 
9 1 . 
92 . 
93. 
9h. 
95. 
96. 
U: 
99. 
100. 
101. 
102, 
103. 
I0if. 
105. 
106. 
107. 
108. 
109. 
110. 
111. 
112, 
113. 
I l l f . 
115. 
116, 
117. 
118, 
119. 
120. 
121, 
122, 
123, 
I2if . 
1 2 j . 
126. 
127. 
128. 
W. 
I .Q. 
S. 
P. 
B.D. 
S.S. 
D. 
AA.K. 
H.K. 
G, 
S,P, 
s . 
N 
L.M. 
R.B. 
M.L. 
A. 
S.S. 
S. 
B. 
S.B. 
A.A. 
A* 
A.A. 
K. 
Q. 
N.S. 
R. 
R. 
S.A. 
S. v^.^. 
M.A. 
R.P.S. 
B.P. 
M.K. 
P.K. 
R.K. 
M.S. 
S. 
Y . 
P.A. 
S.A. 
S.B. 
N, 
^5 
50 
22 
28 
35 
hO 
8 
20 
51 
20 
50 
hO 
80 
17 
22 
60 
35 
70 
M-0 
5^ 
25 
30 
8 
if2 
30 
^5 
61 
30 
30 
65 
hO 
^ 
55 
18 
21+ 
18 
19 
26 
18 
12 
65 
28 
35 
M 
M 
F 
F 
F 
M 
M 
M 
F 
F 
M 
F . 
M 
M 
F 
M 
M 
M 
F 
M 
F 
M 
F 
M 
F 
F 
F 
F 
M 
M 
M 
M 
M 
M 
M 
M 
M . 
M 
F 
M 
M 
M 
F 
F 
17 
19 
13 
15 
15 
19 
19 
17 
10 
19 
20 
15 
I j i 
17 
17 
17 
7 
15 
19 
n 
18 
19 
11+ 
20 
5 
15 
20 
7 
7 
19 
15 
19 
9 
20 
13 
9 
11 
8 
11 
13 
17 
19 
15 
17 
9 
7 
10 
12 
9 
10 
8 
16 
7 
12 
5 
10 
y 
1U-
7 
7 
9 
10 
^h 
10 
12 
11 
^h 
7 
6 
6 
10 
9 
7 
10 
6 
6 
15 
12 
6 
6 
7 
7 
6 
10 
5 
10 
7 
12 
7.0 2 
7.0 1 
9.0 1 
11.0 2 
10,0 1 
11.5 1 
7.0 2 
12.0 1 
12.0 1 
10.0 1 
10,0 
8,5 1 
i u . u 
11,0 
10.0 
13.0 
6.0 
if.O 
11.0 
10.0 
9.0 
9 .0 
11.5 ' 
11.0 
13.0 
6.5 
11.0 : 
10,0 
12.5 
11.5 
11.0 : 
12,0 
7 .0 
8.0 
7.0 
10.5 
6.5 : 
10.0 
9.0 
7.0 
11.0 
12.0 
8.0 
7.5" 
. . 0 
.6 
.7 
- .0 
1.6 
.6 
1,0 
. 0 
.2 
.3 
1.5 
1.2 
1.2 
1.2 
l. lf 
1.0 
12 
1.1 
i .5 
1.0 
1.3 
1.5 
i.O 
1.8 
1.2 
1.3 
1,2 
1.5 
1.8 
t . 2 
^.5 
1.2 
1.0 
1.5 
1.3 
1.2 
>.o 
1.2 
1.0 
1.8 
1.5 
1.2 
1.3 
1.3 
175 
183 
I7O 
195 
200 
209 
155 
171 
210 
175 
157 
210 
2U0 
200 
187 
200 
177 
190 
168 
195 
183 
181 
191 
205 
181 
180 
175 
193 
160 
173 
166 
202 
180 
181 
180 
177 
193 
15^ 
190 
175 
175 
180 
157 
131 
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S.No, Name Age Sex 
129. 
130. 
1 3 1 . 
132. 
133. 
13^4-. 
135. 
136 . 
137. 
138. 
139. 
1U.0. 
I l f l . 
^k2, 
1^-3. 
1»+6. 
1 i f9. 
150 . 
1 5 1 . 
152. 
153. 
15^. 
156 . 
158 
159 
160. 
1 6 1 . 
162. 
163. 
I 6 l f . 
165. 
166, 
167. 
16?. 
169. 
170. 
AST 
lU/L 
ALT 
lU/L 
AIP 
KA/dl 
ACP 
KA/dl 
S.R. 
V.K. 
J* .H. 0 . 
V.K.S. 
S. 
H.A.H. 
R. 
M 
H 
M.L. 
G.A. 
D. 
S.B. 
A.A. 
J . B . 
S.D. 
H. 
K.S. 
S,D» 
L.K. 
E.K. 
T . 
J . S . 
H.S. 
B . S . 
P.K. 
V.K. 
M.P. 
N.S. 
R. 
B.B. 
P . S . 
J . P . 
V.K. 
M.B. 
S.L. 
G. 
S .S . 
N.J . 
S.S, 
M.S. 
22 
^h 
25 
70 
Uif 
68 
18 
69 
60 
32 
60 
1i 
30 
68 
h-0 
^5 
25 
hH 
hB 
50 
15 
12 
hO 
50 
55 
15 
35 
35 
1 
10 
22 
70 
^3 
^5 
19 
65 
65 
18 
h6 
?^ if6 
65 
F 
M 
M 
K 
F 
M 
M 
M 
M 
M 
M 
M 
F 
M 
F 
F 
F 
M 
M 
F 
F 
M 
F 
M 
M 
M 
M 
K 
M 
M 
M 
F 
M 
M 
M 
M 
M 
M 
M 
F 
M 
M 
20 
18 
]l 
11 
5 
6 
1i+ 
17 
13 
13 
11 
19 
7 
5 
19 
11 
13 
9 
20 
19 
19 
17 
16 
19 
13 
15 
19 
17 
15 
17 
15 
17 
19 
18 
15 
11 
19 
17 
15 
17 
19 
114-
9 
12 
11 
10 
5 
12 
11 
^k• 
9 
6 
9 
Itf 
7 
6 
5 
9 
9 
12 
12 
10 
13. ' 
9 
10 
9 
/ 
9 
7 
10 
7 
6 
9 
9 
13 
10 
9 . 
10 
11 
10 
11 
8 
10 .0 
6 , 0 
9 -0 
13 .0 
8 .0 
12 .0 
9 . 0 
11 ,0 
10 ,6 
12 .0 
7 
11 
12 
12 
10 
12 .0 
12 .0 
11 .0 
12 .0 
11 ,0 
6 . 0 
8 .0 
9.0 
9 
12 
8 
7 
12 
11 
9 .0 
10,0 
7 .0 
5.0 
9.0 
13.0 
10,0 
9 
Amylase 
SU/dl 
10.5 
1.2 
1.0 
3.0 
1.0 
2 . 0 
1.5 
1.2 
1.1 
1.0 
1.2 
2 . 0 
1.3 
1.3 
2 , 0 
1.5 
1.0 
1.2 
1.2 
1.3 
1.1 
1.3 
1.W 
1.7 
1.5 
1.3 
1 0 ' 
1.1 
1,6 
1.7 
1,M-
1.2 
1.1 
1.3 
1.5 
1.0 
1.7 
1.2 
2.5 
1.7 
2 . 0 
1.0 
210 
178 
I7lf 
185 
180 
215 
195 
180 
175 
169 
160 
195 
195 
190 
211 
185 
180 
159 
181 
185 
lii 166 
191 
177 
155 
170 
\&/ 
177 
201 
183 
178 
190 
163 
^9^ 
177 
170 
160 
181 
183 
170 
189 
195 
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S.No. Name Age Sex AST 
I U / L 
ALT 
IU/L 
ALP 
KA/dl 
AGP 
KA/dl 
Amylase 
SD/dl 
171. 
172. 
173. 
17^. 
175. 
176. 
177. 
173. 
179. 
IBO. 
181. 
182. 
\Bu 
185. 
186. 
187. 
188. 
189. 
190. 
191. 
192. 
193. 
^9h, 
195. 
196. 
197. 
198. 
199. 
200. 
R.B. 
K. 
M.S. 
A.K. 
R.L. 
R. 
N 
S. 
S, 
N 
A.K. 
L.B. 
M.A. 
A.Z. 
P.S. 
B.A. 
K. 
Z.K. 
M.D. 
S.B. 
M. 
S.A. 
a.s. 
O.B. 
M.D. 
K.L. 
G.S. 
E. 
S.A. 
N. 
^5 
18 
35 
25 
33 
38 
23 
15 
16 
20 
30 
60 
65 
^ 1 
60 
hO 
2 
1+8 
70 
30 
30 
20 
35 
^5 
60 
h5 
60 
35 
1+0 
25 
F 
M 
M 
F 
M 
F 
M 
F 
F 
H 
M 
M 
M 
X' 
M 
M 
M 
M 
F 
F 
F 
M 
F 
M 
F 
M 
M 
F 
M 
F 
13 
19 
18 
19 
19 
h 
9 
11 
6 
11 
7 
17 
19 
19 
17 
13 
9 
13 
9 
h 
9 
7 
9 
6 
7 
6 
7 
11 
9 
17 
6 
8' 
10 
10 
6 
6 
10 
13 
10 
9 
7 
7 
11+ 
6 
11 
6 
6 
6 
7 
9 
9 
6 
9 
7 
l i f 
8.0 
11.5 
11.0 
I'.O 
13.5 
10.0 
8.0 
13.0 
6.5 
5.0 
7.0 
7.5 
8.5 
7.^ " 
7.5 
10.0 
9.5 
10.0 
12.5 
3.0 
13.0 
12.0 
5.5 
6.5 
7.0 
7^0 
7*5 
5.0 
10.0 
8,0 
1.3 
1.2 
1.3 
2.0 
1.7 
1.1 
1.2 
1.6 
1,0 
i.V 
1.1 
1.3 
1.5 
•. "i 
2.0 
1.9 
2.0 
1.9 
1.0 
1.6 
1.5 
1.7 
1.5 
1.7 
1.1 
1.6 
1.2 
1.1 
1.6 
1.2 
19^ 
189 
188 
176 
183 
185 
150 
I8if 
190 
167 
^U 
190 
jc7 
I8if 
205 
188 
201 
1?7 
it>3 
177 
179 
173 
205 
188 
178 
188 
15^ 
205 
19*f 
